Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1050.Time spend outdoors in summer,49085,0.0207374651205885,0.0293403631370159,-0.0367696466279626,0.0782445768691397,0.479703890489105
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1060.Time spent outdoors in winter,45352,0.0398922397633056,0.0336004676047532,-0.0259646767420107,0.105749156268622,0.235141525285203
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1070.Time spent watching television (TV),50662,-0.10716951710606,0.0299053413736413,-0.165783986198397,-0.0485550480137225,0.000339473517789269
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1080.Time spent using computer,45330,0.0794663132259503,0.0316436001033556,0.0174448570233733,0.141487769428527,0.0120365110603025
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1090.Time spent driving,42702,0.0443664360525436,0.034578547594549,-0.0234075172327724,0.11214038933786,0.199486491557807
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1160.Sleep duration,52215,-0.0485021630780029,0.0270827153710221,-0.101584285205206,0.00457995904920035,0.0733218454753815
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34189,0.0197347183366946,0.0137436579105635,-0.00720285116800994,0.0466722878413992,0.15105878247429
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34189,-0.043406100634938,0.0123269797766224,-0.0675669809971178,-0.0192452202727581,0.000431519200928665
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34189,-0.0128616457283242,0.0146992645045725,-0.0416722041572863,0.0159489127006378,0.381603287464883
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34189,-0.0420727664705829,0.0150260195291552,-0.071523764747727,-0.0126217681934387,0.00512041920461493
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34189,-0.0316363181156821,0.015223532389477,-0.061474441599057,-0.00179819463230722,0.0377244951791793
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34189,-0.0175221787117916,0.0290836246479633,-0.0745260830217997,0.0394817255982166,0.546871527180207
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34189,-0.0683844082397071,0.0291401003700193,-0.125499004964945,-0.0112698115144693,0.0189581003473767
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34189,-0.0157572814159784,0.0223784548898506,-0.0596190530000856,0.0281044901681288,0.481370327931506
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34189,-0.041034303031926,0.0160734861795072,-0.0725383359437601,-0.00953027012009185,0.0106975599628183
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34189,-0.0380974353118538,0.011052592236226,-0.0597605160948566,-0.0164343545288509,0.000569405687950862
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34189,-0.0169467746887803,0.0153966849866581,-0.0471242772626301,0.0132307278850695,0.271064535619431
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34189,-0.0252486551182751,0.00944083190817406,-0.0437526856582963,-0.00674462457825397,0.00749858940477672
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34189,-0.0221200373132649,0.0117530165414611,-0.0451559497345286,0.000915875107998801,0.0598558772871023
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34189,-0.0497890316697639,0.016861022142406,-0.0828366350688798,-0.0167414282706481,0.00315548629843296
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34189,-0.0307429747197402,0.0160133422931073,-0.0621291256142306,0.000643176174750189,0.0549079315351226
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34189,-0.0202636653010779,0.0224408774364818,-0.0642477850765821,0.0237204544744264,0.366558804677517
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34189,-0.0157874409837256,0.0208293275551606,-0.0566129229918403,0.0250380410243892,0.448503508168009
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34189,-0.029110219073984,0.012557153597793,-0.0537222401256583,-0.0044981980223097,0.0204580900895676
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34189,-0.0227784651160986,0.0117390528845731,-0.045787008769862,0.000230078537664689,0.05235985530172
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34189,0.00343024260617941,0.0156356168295945,-0.0272155663798259,0.0340760515921847,0.826353616054119
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120040.Fatigue severity over the past week,34195,-0.110011167353068,0.0472678972956383,-0.202656246052519,-0.0173660886536172,0.0199645239650547
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120041.Waking unrefreshed severity over the past week,34192,-0.121511832391157,0.0472423213663428,-0.214106782269189,-0.0289168825131254,0.0101231447926287
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120042.Cognitive symptoms severity over the past week,34192,-0.0485772377193928,0.0501982412222928,-0.146965790515087,0.049811315076301,0.333214273186872
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120098.Mobility problems today,34199,-0.20465276338898,0.0557112161453179,-0.313846747033803,-0.0954587797441564,0.000240573003356005
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120099.Self-care problems today,34199,-0.445080207597071,0.0867271704642984,-0.615065461707096,-0.275094953487047,2.92271131457471e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120100.Problems doing usual activities,34199,-0.176153570458702,0.0528941411173016,-0.279826087048613,-0.0724810538687912,0.000870734725140054
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120101.Pain or discomfort today,34199,-0.128268065842644,0.0474836480934237,-0.221336016105755,-0.035200115579534,0.00691863489284424
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120102.Anxiety or depression today,34199,-0.089536845737431,0.0553549986775655,-0.198032643145459,0.0189589516705974,0.105802236751896
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120103.Scale to indicate how health is today,34160,0.0127456708055207,0.00407286875310476,0.00476284804943541,0.0207284935616061,0.00175677499990798
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34174,-0.0723946765159295,0.0568107882780068,-0.183743821540823,0.0389544685089639,0.202583284952708
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34151,-0.0959889967448719,0.0570906890331598,-0.207886747249865,0.0159087537601213,0.0927286269498821
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34181,-0.0933187882405997,0.0466653518613562,-0.184782877888858,-0.00185469859234166,0.0455556023882239
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34175,-0.117524668515668,0.0481037384526196,-0.211807995882803,-0.023241341148534,0.0145773376393579
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34184,-0.034220373191326,0.0577019805938678,-0.147316255155307,0.0788755087726548,0.553158997229167
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120109.Feeling bad about self over the last two weeks,34153,-0.0347006994846462,0.059725296541603,-0.151762280706188,0.0823608817368957,0.561250543626151
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120110.Trouble concentrating over the last two weeks,34179,-0.0840191012217979,0.0617802283709413,-0.205108348828843,0.0370701463852471,0.173871741932589
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34170,-0.193684162926234,0.0897297112250151,-0.369554396927264,-0.0178139289252044,0.0309111565454226
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34132,-0.0470350301069064,0.120165464856743,-0.282559341226123,0.18848928101231,0.695496265948611
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31787,-0.172566889711574,0.0616336700583109,-0.293368883025864,-0.051764896397285,0.00512552848806618
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49841,-0.0351388424531627,0.066090696703615,-0.164676607992248,0.0943989230859227,0.594955014564996
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47965,-0.0819150300193556,0.042921311949545,-0.166040801440464,0.00221074140175263,0.0563396717651711
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1289.Cooked vegetable intake,51670,-0.126463671127265,0.0282971067920382,-0.18192600043966,-0.0710013418148701,7.88520755132079e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1299.Salad  or  raw vegetable intake,51162,-0.0218578642681233,0.0306281115727607,-0.0818889629507343,0.0381732344144878,0.475447596474785
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1309.Fresh fruit intake,51717,-0.0101517307226622,0.0293120007724947,-0.0676032522367519,0.0472997907914275,0.729094693428461
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1319.Dried fruit intake,49939,-0.000434162340233843,0.0295823179624554,-0.0584155055466464,0.0575471808661787,0.988290451255828
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X134.Number of self-reported cancers,52507,0.0224041083435347,0.0486285614997524,-0.0729078721959799,0.117716088883049,0.645003702900609
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X135.Number of self-reported non-cancer illnesses,52507,-0.236675296623034,0.028315673248003,-0.29217401618912,-0.181176577056948,6.64468400937456e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X136.Number of operations, self-reported",52507,0.0557512518745341,0.028470630487817,-5.11838815871607e-05,0.111553687630655,0.0502161841465896
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X137.Number of treatments or medications taken,52507,-0.347409313393924,0.0277656367575319,-0.401829961438686,-0.292988665349161,7.98074950754198e-36
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1438.Bread intake,51550,0.00309962672297538,0.00269498271613877,-0.00218253940065661,0.00838179284660737,0.250093414224715
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1458.Cereal intake,51095,-0.0293112708272327,0.028083260084775,-0.0843544605933917,0.0257319189389262,0.296620953239611
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1488.Tea intake,51576,-0.00685955466684578,0.00251517954236475,-0.0117893065698807,-0.00192980276381087,0.00639032864768961
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1498.Coffee intake,50286,-0.192719056312311,0.0285013530359814,-0.248581708262834,-0.136856404361787,1.392384911855e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1528.Water intake,50750,0.0250485453372704,0.0288293092187531,-0.0314569007314857,0.0815539914060266,0.384933314857224
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1568.Average weekly red wine intake,41601,-0.00255987822471496,0.0346833192695765,-0.0705391839930849,0.065419427543655,0.94116466924559
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41601,0.0756349199928184,0.0349727182621077,0.00708839219908734,0.144181447786549,0.0305793103485062
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1588.Average weekly beer plus cider intake,41625,-0.00592528070180897,0.043836556072902,-0.0918449306046968,0.0799943692010789,0.8924809724645
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1598.Average weekly spirits intake,41555,-0.0829354765717165,0.0389395866063075,-0.159257066320079,-0.0066138868233538,0.0331982392112429
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1608.Average weekly fortified wine intake,41632,-0.0294117716516684,0.0593660967283521,-0.145769321239238,0.0869457779359017,0.620302646378509
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1737.Childhood sunburn occasions,45839,-0.0139058523275777,0.0336232732023955,-0.0798074678042729,0.0519957631491175,0.679187198828953
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1807.Father's age at death,44920,0.00885725741086807,0.00290230817434987,0.00316873338914232,0.0145457814325938,0.00227766775580652
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1845.Mother's age,35396,-0.00226902105732628,0.00650114128150052,-0.0150112579690673,0.0104732158544147,0.727081849147111
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1873.Number of full brothers,51984,0.0612087687567851,0.0272387353879814,0.00782084739634155,0.114596690117229,0.0246401017001261
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1883.Number of full sisters,51991,-0.0436403618150033,0.0272328192793768,-0.0970166876025819,0.00973596397257527,0.109058431655885
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20015.Sitting height,52313,0.0345497280567178,0.00332137364965978,0.0280398357033846,0.0410596204100509,2.69444939234284e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20016.Fluid intelligence score,33448,0.137597156506551,0.0449059215296266,0.0495815503084828,0.225612762704619,0.00218957885762693
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20018.Prospective memory result,33792,-0.187927039004366,0.0588018920937764,-0.303178747508168,-0.0726753305005644,0.00139842279656124
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33319,-0.00884913916585462,0.00463643895614462,-0.0179365595198981,0.000238281188188841,0.0563450818225491
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33295,-0.0107475311898493,0.0046086489910465,-0.0197804832123004,-0.00171457916739813,0.0197211775837711
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20023.Mean time to correctly identify matches,52191,-0.00691585752540233,0.00272595528916935,-0.0122587298921743,-0.00157298515863041,0.0111848495272802
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#1.Illnesses of father_Heart disease,49230,0.00306245632308271,0.0055531789483755,-0.00782177441573328,0.0139466870618987,0.581310979446035
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48792,0.0217148162897083,0.0120271724075411,-0.00185844162907225,0.0452880742084889,0.0710119914495859
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48761,0.00627544352346005,0.0163851875563492,-0.0258395240869845,0.0383904111339046,0.701726882881059
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#12.Illnesses of father_Severe depression,48777,0.0289961015073298,0.0132353348077422,0.00305484528415513,0.0549373577305044,0.0284750116193063
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48780,-0.0071918423374551,0.00991550333073773,-0.026626228865701,0.0122425441907908,0.468267078615924
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#2.Illnesses of father_Stroke,48945,0.00433379491308952,0.0072156468033738,-0.00980887282152313,0.0184764626477022,0.548104845168908
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48880,-0.00781529843181627,0.00907465959759505,-0.0256016312431026,0.00997103437947002,0.389124120705999
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48789,0.00634348267950582,0.0115872608205888,-0.0163675485288482,0.0290545138878599,0.584072454620485
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48938,-0.0140282017676266,0.00816561690915236,-0.0300328109095652,0.00197640737431207,0.0858165867648806
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48999,0.000724623532861741,0.00616380198135174,-0.0113564283505877,0.0128056754163112,0.906416366035084
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#9.Illnesses of father_Diabetes,48868,-0.00269818461376241,0.00860680409795064,-0.0195675206457457,0.0141711514182208,0.75390777662801
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50633,0.00260946612828407,0.00618605001830663,-0.00951519190759693,0.0147341241641651,0.673152021577975
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50497,0.00851297274468768,0.00902484485074949,-0.00917572316278132,0.0262016686521567,0.345545484097199
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50430,0.00756290078985361,0.0193560796995453,-0.0303750154212552,0.0455008170009625,0.696003853430381
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50469,-0.0126391629479965,0.00972844578703556,-0.0317069166905862,0.00642859079459322,0.193888007052635
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#2.Illnesses of mother_Stroke,50565,0.00871607487698975,0.00711796267102683,-0.00523513195822284,0.0226672817122023,0.2207678493417
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50454,-0.00297425189228055,0.0131684377920788,-0.028784389964755,0.0228358861801939,0.821310399238035
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50450,0.00852474750723713,0.011676676255414,-0.0143615379533743,0.0314110329678486,0.465356254405069
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50478,0.00275604044507951,0.00926401724966697,-0.0154014333642678,0.0209135142544268,0.76608756865248
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50496,0.0211581620212499,0.0103564562306061,0.000859507809261893,0.0414568162332378,0.0410632287074151
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50660,0.00761280025648054,0.00537422095815852,-0.00292067282151015,0.0181462733344712,0.156629276199635
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50511,-0.0178168882903908,0.00845787083084516,-0.0343943151188473,-0.00123946146193428,0.0351665447504516
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46946,-0.0326882015601591,0.00877531282553632,-0.0498878146982103,-0.015488588422108,0.000195778185164506
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46799,0.00253206032561586,0.0343798139354552,-0.0648523749878764,0.0699164956391081,0.941289844275495
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46796,0.059649746203831,0.0357580514734125,-0.0104360346840575,0.129735527091719,0.0953002283920243
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46861,-0.00727202805192648,0.00969188902991034,-0.0262681305505508,0.0117240744466978,0.453069264216674
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46811,-0.00270106225251862,0.0206261212532786,-0.0431282599089447,0.0377261354039074,0.895813290146109
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46825,-0.0419025448564319,0.0149749928319381,-0.0712535308070306,-0.0125515589058331,0.0051437323041707
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46806,-0.0502165261062977,0.0181301144863046,-0.0857515504994547,-0.0146815017131406,0.00561395067350269
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46804,-0.00434117529741672,0.0176407089072816,-0.0389169647556886,0.0302346141608552,0.805615997704616
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46823,0.0111694537239079,0.01293007850391,-0.0141735001437556,0.0365124075915715,0.387687826657414
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46825,-0.000502194943983183,0.0155886669272343,-0.0310559821213624,0.0300515922333961,0.974300572554536
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47018,0.00211235269535065,0.00646928936711885,-0.0105674544642023,0.0147921598549036,0.744033949376201
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46899,-0.03467940640571,0.00930537549566151,-0.0529179423772065,-0.0164408704342134,0.000194390886627988
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20127.Neuroticism score,46500,-0.0057834686230842,0.0286419534296177,-0.0619216973451348,0.0503547600989664,0.839978799598783
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33448,0.0887507444891918,0.0456370107783888,-0.000697796636450351,0.178199285614834,0.0518410696738887
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20161.Pack years of smoking,31933,-0.0219357232250795,0.00554149059356832,-0.0327970447884735,-0.0110744016616856,7.61356686084734e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31933,-0.0219054200818296,0.00546678573087329,-0.0326203201143413,-0.011190520049318,6.20907836148828e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20191.Fluid intelligence score,31577,0.155970628537401,0.0508101858315247,0.0563826643076122,0.255558592767189,0.00215101247209557
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31577,0.0893798075182017,0.0521024466115605,-0.0127409878404569,0.19150060287686,0.086303965281803
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20240.Maximum digits remembered correctly,30813,0.0690207917214999,0.0545065669816964,-0.037812079562625,0.175853663005625,0.205457863621665
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20255.Spirometry QC measure,46040,-0.025322968877862,0.0380012109210911,-0.0998053422832005,0.0491594045274765,0.505180038818824
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20261.avMSE,30545,-0.0074849148829221,0.00530831024257713,-0.0178892029583733,0.00291937319252907,0.158579743873467
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20262.Myopia diagnosis,30545,0.0273984643074726,0.0685808186705911,-0.107019940286886,0.161816868901831,0.689534239372985
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20280.Glucose-lactate,40472,-0.0142678212371679,0.00346692754307708,-0.0210629992215989,-0.00747264325273679,3.8842904326187e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20281.Spectrometer-corrected alanine,40509,0.00644481490773244,0.00331714081950814,-5.67810985035166e-05,0.0129464109139684,0.0520478104760453
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33269,0.0157075503756389,0.0158126251515461,-0.0152851949213915,0.0467002956726693,0.320564239460263
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33266,0.0490449494688174,0.0297312388522187,-0.00922827868153128,0.107318177619166,0.0990583586144705
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33264,-0.02390287692831,0.0368582753554852,-0.0961450966250609,0.0483393427684409,0.516673503505502
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33264,0.0118414512238008,0.0148372172739107,-0.0172394946330641,0.0409223970806657,0.424839125791541
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33264,-0.0535970577098375,0.0292603079463972,-0.110947261284776,0.003753145865101,0.0670250175223596
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33271,-0.00251441113764974,0.0358993226273611,-0.0728770834872774,0.0678482612119779,0.944162909806436
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33271,0.00817706503015079,0.0238369126919018,-0.0385432838459768,0.0548974139062783,0.731574950891977
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33271,0.00596728818638148,0.0262211221676545,-0.0454261112622213,0.0573606876349843,0.819981449017251
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33271,0.0291217075672708,0.0430279875362959,-0.0552131480038692,0.113456563138411,0.498545217562062
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33271,0.0606360380521028,0.0519268865377493,-0.0411406595618858,0.162412735666091,0.242951496793987
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33271,0.0128408726953596,0.0271462640599797,-0.0403658048622007,0.0660475502529199,0.63620675749762
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33271,0.0755697815451572,0.0523546134339057,-0.027045260785298,0.178184823875612,0.14893725331392
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33271,-0.0439182225537085,0.0358766393667117,-0.114236435712463,0.0263999906050464,0.220930088397509
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33270,-0.0844122771522723,0.042765920633524,-0.168233481593979,-0.00059107271056516,0.0484332527890245
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33270,-0.0101691162788687,0.0200733358565589,-0.0495128545577241,0.0291746219999868,0.612449421552092
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33270,-0.00601108974727252,0.0324304557993199,-0.0695747831139395,0.0575526036193945,0.852956252399216
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33272,0.0591450940797076,0.0476963294879544,-0.0343397117166831,0.152629899876098,0.214995622553742
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20600.Liking for adding salt to foods,35140,0.0354962036232636,0.0419332580705159,-0.0466929821949475,0.117685389441475,0.397296822447185
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20601.Liking for aniseed,35140,-0.0222523344968381,0.0420535917033554,-0.104677374235415,0.0601727052417384,0.596717733667838
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20602.Liking for apple juice,35140,0.0726534972046845,0.0419727163511869,-0.00961302684364179,0.154920021253011,0.0834860660716353
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20603.Liking for apples,35140,-0.0449339557164539,0.0429542158221444,-0.129124218727857,0.0392563072949491,0.295543372525378
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20604.Liking for asparagus,35140,-0.00368350448432056,0.0431044950578341,-0.0881683147976753,0.0808013058290342,0.931901089497839
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20605.Liking for aubergine,35140,0.00398790209571979,0.0420137021478375,-0.0783589541140417,0.0863347583054813,0.924380879528355
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20606.Liking for avocados,35140,0.0341304405228184,0.0431136970156252,-0.0503724056278069,0.118633286673444,0.428589370661319
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20607.Liking for bacon,35140,-0.0650201715161708,0.0421335712739446,-0.147601971213102,0.0175616281807606,0.122813935508975
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20608.Liking for baked or steamed fish,35140,-0.147654477468155,0.0429369329626537,-0.231810866074957,-0.0634980888613542,0.000586380959808234
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20609.Liking for bananas,35140,-0.035799794835457,0.0438038768948858,-0.121655393549433,0.0500558038785191,0.413789766154483
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35140,-0.102618411493468,0.0421317018737634,-0.185196547166045,-0.0200402758208922,0.0148809815470584
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20611.Liking for beef steak,35140,-0.0893659883034991,0.0422156544140275,-0.172108670954993,-0.00662330565200525,0.0342920609501677
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20612.Liking for beetroot,35140,-0.04078304188615,0.0431680452475905,-0.125392410571427,0.0438263267991273,0.344807529697754
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20613.Liking for bell pepper,35140,-0.0116589977759933,0.0422639515471377,-0.0944963428083832,0.0711783472563966,0.782659770405943
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20614.Liking for bicycling,35140,0.195956015723569,0.0417844656876,0.114058462975873,0.277853568471265,2.77016690491605e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20615.Liking for biscuits,35140,0.0566520950398847,0.0420281996423306,-0.0257231762590832,0.139027366338853,0.177701653802763
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20616.Liking for bitter foods,35140,0.0282389278340344,0.0419640869828504,-0.0540106826523525,0.110488538320421,0.50100585924623
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20617.Liking for bitter or ale,35140,0.00426833997002808,0.0435475042613276,-0.081084768382174,0.0896214483222301,0.92192165050832
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20618.Liking for black olives,35140,-0.0021126040909561,0.0426845995240256,-0.0857744191580463,0.0815492109761341,0.960527057248305
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20619.Liking for black pepper,35140,0.0173451349859235,0.042660290791171,-0.0662690349647716,0.100959304936619,0.684319230646144
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20620.Liking for blue cheese,35140,-0.0899248580508183,0.0424106868969245,-0.17304980436879,-0.00679991173284636,0.0340008067912366
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20621.Liking for bolognese sauce,35140,-0.0402199719361982,0.0424585226910507,-0.123438676410658,0.0429987325382612,0.343519202573622
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20622.Liking for broad beans,35140,-0.018674399630155,0.0419603822187284,-0.100916748778863,0.0635679495185526,0.656293820716645
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20623.Liking for broccoli,35140,-0.0487695785195119,0.0439985823936657,-0.135006800011097,0.0374676429720729,0.267698862578273
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20624.Liking for brown rice,35140,0.0191698150253857,0.0421520581527509,-0.063448218954006,0.101787849004777,0.649278436893997
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20625.Liking for brussel sprouts,35140,-0.0647474206414421,0.0425055031661016,-0.148058206847001,0.0185633655641171,0.127720410212244
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20626.Liking for burgers (meat),35140,-0.111244271292677,0.0419509514170747,-0.193468136070143,-0.0290204065152104,0.00801893563930086
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20627.Liking for burn of spicy foods,35140,-0.0498398309199521,0.0420668976558538,-0.132290950325425,0.0326112884855214,0.236132576533267
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20628.Liking for butter on bread,35140,0.026085717800741,0.0426722287725105,-0.0575518505933796,0.109723286194862,0.541011143428051
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20629.Liking for butternut squash,35140,0.0578668991897533,0.0420511467043252,-0.024553348350724,0.140287146730231,0.168817203773817
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20630.Liking for cabbage,35140,-0.00765971215967098,0.0427708470220342,-0.091490572322858,0.076171148003516,0.857872612931028
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20631.Liking for cake,35140,-0.0067557302599044,0.04234228034614,-0.0897465997383387,0.0762351392185299,0.873238224369716
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20632.Liking for cake icing,35140,0.013290457763711,0.0418607499996688,-0.0687566122356399,0.095337527763062,0.750876434016528
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20633.Liking for capers,35140,-0.0196167881563987,0.0421247099863411,-0.102181219729627,0.06294764341683,0.641451463430023
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20634.Liking for cauliflower,35140,-0.112083433538943,0.0429417351342198,-0.196249234402014,-0.0279176326758724,0.00906346472452694
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20635.Liking for cereal or granola bar,35140,0.0248532559490077,0.041598057569843,-0.0566789368878845,0.1063854487859,0.550211681948247
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20636.Liking for cheesecake,35140,-0.0511917870115964,0.0419421741813383,-0.133398448407019,0.0310148743838267,0.22229002376335
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20637.Liking for cherries,35140,-0.037728729749645,0.0457181782835591,-0.127336359185421,0.0518788996861309,0.409250550251443
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20638.Liking for chicken,35140,-0.124569654215483,0.0448751181643905,-0.212524885817688,-0.0366144226132774,0.00551418887387493
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20639.Liking for chilli pepper,35140,-0.00496000007489497,0.0422912437345899,-0.0878508377946912,0.0779308376449012,0.90663882354691
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20640.Liking for chips or french fries,35140,0.0659839601133918,0.042362262594377,-0.017046074571587,0.149013994798371,0.119354932681888
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20641.Liking for cigarette smoking,35140,-0.0936779261476233,0.0693000200763668,-0.229505965497302,0.0421501132020555,0.176476435015978
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20642.Liking for cod,35140,-0.156428324152191,0.0431199535950016,-0.240943433198394,-0.0719132151059876,0.000287237517203415
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20643.Liking for coffee with sugar,35140,-0.0184893906693767,0.0478999206119337,-0.112373235068767,0.0753944537300132,0.699504028735593
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20644.Liking for coffee without sugar,35140,-0.11543071196703,0.0432799535688654,-0.200259420962006,-0.0306020029720534,0.00766308611440802
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20645.Liking for coriander,35140,-0.0363886603127981,0.0421923836225186,-0.119085732212935,0.0463084115873384,0.388461401172367
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20646.Liking for corn flakes,35140,-0.0131974630291845,0.0417021400189185,-0.0949336574662648,0.0685387314078958,0.75165221867696
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20647.Liking for cream,35140,0.00611639678668105,0.0417846761294096,-0.0757815684269619,0.088014362000324,0.883625011125043
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20648.Liking for croissant,35140,-0.0026336928259692,0.0420318907174984,-0.0850161986322661,0.0797488129803277,0.950038904923078
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20649.Liking for cucumber,35140,-0.00478208779688707,0.042455071051617,-0.0879940270580564,0.0784298514642822,0.910319048581143
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20650.Liking for curry,35140,-0.0642800641098929,0.0424041569320862,-0.147392211696782,0.0188320834769961,0.129576608333227
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20651.Liking for dairy products,35140,-0.00269962108616424,0.0425241183183259,-0.086046892990083,0.0806476508177545,0.94938191414028
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20652.Liking for dark chocolate,35140,-0.123530738523726,0.0421993844569078,-0.206241532059265,-0.0408199449881868,0.00342627747736464
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20653.Liking for diet fizzy drinks,35140,-0.0588885673450634,0.0442208109191183,-0.145561356746535,0.0277842220564085,0.182989342290884
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20654.Liking for dried fruit,35140,-0.0310025623564529,0.0422726187465835,-0.113856895099757,0.0518517703868508,0.463333140302073
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20655.Liking for eggs,35140,-0.109910793767409,0.0434060791352152,-0.194986708872431,-0.0248348786623873,0.0113506900186031
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20656.Liking for exercising alone,35140,0.108321825990863,0.0421591845944506,0.0256898241857397,0.190953827795986,0.0102023106172806
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20657.Liking for exercising with others,35140,0.0873315842958182,0.0422228489000801,0.00457480045166116,0.170088368139975,0.0386312400966941
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20658.Liking for extra virgin olive oil,35140,0.0112019987641738,0.0428218059860265,-0.0727287409684381,0.0951327384967858,0.793638232392305
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20659.Liking for fatty foods,35140,0.0864708838627465,0.0419412862781667,0.00426596275753975,0.168675804967953,0.0392592371948198
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20660.Liking for fresh tomatoes,35140,-0.0882549640549517,0.0465167714950773,-0.179427836185303,0.00291790807539975,0.0578190100641864
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20661.Liking for fried chicken,35140,-0.0603217276312421,0.0417277553331759,-0.142108128084267,0.0214646728217827,0.14831820277804
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20662.Liking for fried or battered fish,35140,-0.037154373211606,0.0424267091289592,-0.120310723104366,0.0460019766811539,0.38119612872908
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20663.Liking for fruit,35140,-0.0670339577687678,0.0490170074037308,-0.16310729228008,0.0290393767425446,0.171476968405899
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20664.Liking for garlic,35140,0.0257186860399038,0.0427663978216792,-0.0581034536905874,0.109540825770395,0.547602332998755
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20665.Liking for gherkins,35140,-0.0813402632853828,0.0420021902104572,-0.163664556097879,0.000984029527113392,0.052824037952842
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20666.Liking for globe artichoke,35140,0.0299778401392745,0.0424522391135514,-0.0532285485232863,0.113184228801835,0.480107460690212
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20667.Liking for goat's cheese,35140,-0.0450715183946063,0.0417557979391114,-0.126912882355265,0.0367698455660521,0.280430520059134
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20668.Liking for going to a cafe,35140,-0.0896149401365882,0.0424648782302616,-0.172846101467901,-0.00638377880527545,0.0348530652458696
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20669.Liking for going to the gym,35140,0.0698167163809719,0.0420723164168133,-0.0126450237959821,0.152278456557926,0.0970554163407065
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20670.Liking for going to the pub,35140,-0.0338353647390125,0.0420935891627767,-0.116338799498055,0.0486680700200299,0.421523002178606
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20671.Liking for grapefruit,35140,0.0572334128961805,0.0419150549884106,-0.0249200948811042,0.139386920673465,0.172136663648365
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20672.Liking for green olives,35140,0.0166809502044672,0.0422295983100684,-0.0660890624832669,0.0994509628922013,0.692846253163606
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20673.Liking for haddock,35140,-0.144816175292674,0.0431141859173568,-0.229319979690693,-0.0603123708946542,0.000785275689015732
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20674.Liking for ham,35140,-0.0498812981326027,0.0419536956136061,-0.132110541535271,0.0323479452700653,0.23448154258684
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20675.Liking for hard cheese,35140,-0.0326029175980398,0.0431626042176361,-0.117201621864606,0.0519957866685269,0.45005504592169
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20676.Liking for herring,35140,-0.0559337341588105,0.0420170419654857,-0.138287136411162,0.0264196680935414,0.183146556679359
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20677.Liking for honey,35140,0.0162739813455753,0.0421550265684022,-0.0663498707284931,0.0988978334196436,0.699466743840409
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20678.Liking for horseradish or wasabi,35140,-0.0122160722518807,0.0420421382976779,-0.0946186633153294,0.070186518811568,0.771387884775739
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20679.Liking for ice cream,35140,-0.00635863554446464,0.0422676839499446,-0.0892032960863561,0.0764860249974269,0.880422469362314
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20680.Liking for jam,35140,0.0127428024727264,0.0419285650160123,-0.0694371849586576,0.0949227899041105,0.761197069294319
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20681.Liking for kiwi fruit,35140,0.050450249625165,0.0422919106366713,-0.0324418952227107,0.133342394473041,0.2329329175147
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20682.Liking for lager,35140,-0.016340407117025,0.0425649928798198,-0.0997677931614718,0.0670869789274218,0.701065322696486
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20683.Liking for lamb,35140,-0.101013611575106,0.0423880109460503,-0.184094113029364,-0.0179331101208472,0.0171862950827048
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20684.Liking for lemons,35140,0.0137358689441297,0.0424860388932874,-0.0695367672867136,0.097008505174973,0.746472021531297
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20685.Liking for lentils or beans,35140,0.0515158838114118,0.0427226308550664,-0.0322204726645184,0.135252240287342,0.227912885846737
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20686.Liking for liver,35140,-0.110393244590273,0.0425050382126553,-0.193703119487077,-0.0270833696934681,0.00941215023447847
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20687.Liking for mackerel,35140,-0.0499128216948436,0.0422167923932773,-0.132657734785667,0.0328320913959799,0.237113873342704
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20688.Liking for marzipan,35140,-0.0246732555443669,0.0417716647761461,-0.106545718505613,0.0571992074168795,0.554754272050461
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20689.Liking for mayonnaise,35140,-0.0682199793263237,0.0421310132287708,-0.150796765254715,0.0143568066020671,0.105426401927769
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20690.Liking for melon,35140,-0.0293810596145591,0.0442555666546567,-0.116121970257686,0.057359851028568,0.506771701793153
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20691.Liking for milk chocolate,35140,0.0382245323871824,0.042302025014832,-0.0446874366418884,0.121136501416253,0.366222624763842
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20692.Liking for mushrooms,35140,-0.0432683668231666,0.0438330818589823,-0.129181207266772,0.0426444736204387,0.323607799320705
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20694.Liking for orange juice,35140,0.0419304293884825,0.0417911854418457,-0.0399802940775351,0.1238411528545,0.31572348419045
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20695.Liking for oranges,35140,-0.0321030598159688,0.0431539608087202,-0.11668482300106,0.0524787033691229,0.456941729080739
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20696.Liking for pasta,35140,-0.0340618990940431,0.0424771955253971,-0.117317202323821,0.0491934041357353,0.422636330287033
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20697.Liking for pears,35140,0.0391740060595248,0.0432809559795429,-0.0456566676603793,0.124004679779429,0.365427778798513
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20698.Liking for pizza,35140,0.00904276288342308,0.0421332097760421,-0.0735383282776194,0.0916238540444655,0.830065228841913
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20699.Liking for plain yogurt,35140,0.00553151968011092,0.0424467285977689,-0.0776640683715162,0.088727107731738,0.896318283756514
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20700.Liking for plums,35140,-0.0264735925966257,0.0432431539381414,-0.111230174315383,0.0582829891221314,0.54041642974675
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20701.Liking for pollock,35140,-0.0867711481600988,0.0418800938200452,-0.168856132047387,-0.00468616427281029,0.038299201894816
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20702.Liking for pork chop,35140,-0.0660072857081718,0.0421161961081952,-0.148555030080234,0.0165404586638909,0.117082138657315
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20703.Liking for porridge,35140,-0.0253569128129495,0.0431772074974065,-0.109984239507866,0.0592704138819672,0.557031160221999
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20704.Liking for potato crisps,35140,0.0345626903163204,0.0422894892628445,-0.0483247086388549,0.117450089271496,0.413782119836129
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20705.Liking for potatoes,35140,0.0235223428885177,0.0426323839257155,-0.0600371296058846,0.10708181538292,0.581132396730069
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20706.Liking for prawns,35140,-0.13725154946804,0.0431311170815291,-0.221788538947837,-0.0527145599882431,0.00146582931850612
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20707.Liking for raw carrots,35140,-0.013359139652378,0.0428522977954066,-0.097349643331375,0.0706313640266189,0.755237750017949
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20708.Liking for red meat,35140,-0.081199522232257,0.0420021899113848,-0.163523814458571,0.00112476999405732,0.053235360659716
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20709.Liking for red wine,35140,0.0259410113408212,0.041988564774713,-0.0563565756176163,0.108238598299259,0.536712883675727
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35140,0.0289868060461779,0.0442297267966408,-0.0577034584752381,0.115677070567594,0.512244115706329
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20711.Liking for roast chicken,35140,-0.123767755002474,0.0448450860436098,-0.211664123647949,-0.0358713863569988,0.00579184108087283
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20712.Liking for salad dressing,35140,-0.00415395566920746,0.0417851090386385,-0.086052769384939,0.077744858046524,0.920812747539318
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20713.Liking for salad leaves,35140,0.00432739712759267,0.043605726670538,-0.0811398271466619,0.0897946214018472,0.920950219580538
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20714.Liking for salami,35140,-0.00625905507446756,0.0421072417751225,-0.0887892489537077,0.0762711388047726,0.881836117187272
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20715.Liking for salmon,35140,-0.155375969568317,0.0450145983544823,-0.243604582343102,-0.0671473567935319,0.000559265946805903
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20716.Liking for salty foods,35140,0.034675705228116,0.0416210357788274,-0.0469015248983857,0.116252935354618,0.404790431843876
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20717.Liking for salty pretzels,35140,0.014954201069148,0.0420847147117753,-0.0675318397659316,0.0974402419042276,0.72234514012559
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20718.Liking for sardines,35140,-0.107335227923207,0.042026561997405,-0.189707289438121,-0.0249631664082932,0.0106635314687803
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20719.Liking for sausages (meat),35140,-0.0628552271964451,0.0418972352320235,-0.144973808251211,0.0192633538583209,0.133586016770211
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20720.Liking for savoury biscuits,35140,0.016722948235031,0.0422945239059046,-0.0661743186205421,0.099620215090604,0.692560954543143
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35140,-0.105287409037915,0.0422030565367861,-0.188005399850016,-0.0225694182258145,0.0126184555874821
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20722.Liking for skimmed milk,35140,-0.0145550843641415,0.0421271314539102,-0.0971242620138054,0.0680140932855224,0.729722452834847
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20723.Liking for smoked fish,35140,-0.0926062617697575,0.0421715700929231,-0.175262539151887,-0.00994998438762831,0.0281176250940942
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20724.Liking for soft cheese,35140,-0.0771680915598005,0.042098977598589,-0.159682087653035,0.00534590453343399,0.066828042548675
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20725.Liking for soy sauce,35140,-0.0660878487987304,0.0420444344237506,-0.148494940269282,0.0163192426718207,0.116013287749916
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20726.Liking for soya milk,35140,-0.0216906112469968,0.0420714722424649,-0.104150696842228,0.0607694743482344,0.606168391066954
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20727.Liking for spicy foods,35140,-0.0456934930713843,0.0421498576623757,-0.128307214089641,0.036920227946872,0.278357218152294
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20728.Liking for spinach,35140,-0.00950365199730531,0.0426873319371604,-0.0931708225941398,0.0741635185995292,0.823824620271701
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20729.Liking for spirits,35140,-0.0277680731906025,0.0419430796366972,-0.109976509278529,0.054440362897324,0.507958699872772
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20730.Liking for strawberries,35140,-0.0315297100151341,0.0481537222486941,-0.125911005622575,0.0628515855923064,0.512628649586866
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35140,-0.103630070014498,0.0438046120890312,-0.189487109708999,-0.0177730303199971,0.0180121153820437
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20732.Liking for sweet foods,35140,0.0446180432075437,0.0419081441191537,-0.0375219192659976,0.126758005681085,0.287052609202081
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20733.Liking for taking the stairs,35140,0.0836826378977202,0.0434250268282149,-0.00143041468558107,0.168795690481021,0.0539986348377796
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20734.Liking for tea with sugar,35140,-0.0265795858536889,0.0558458287828414,-0.136037410268058,0.0828782385606802,0.634122751050444
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20735.Liking for tea without sugar,35140,0.00833620919219232,0.0450642800466143,-0.0799897796991718,0.0966621980835564,0.853244429449467
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20736.Liking for tomato ketchup,35140,-0.0452796515371554,0.0416822178224891,-0.126976798469234,0.0364174953949233,0.277368065679905
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20737.Liking for tinned tuna,35140,-0.0833537300794972,0.0421250219499512,-0.165918773101401,-0.000788687057592899,0.04787290542746
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20738.Liking for turnip (white),35140,-0.0574878663447159,0.0419830413847103,-0.139774627458748,0.0247988947693164,0.170930683448621
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20739.Liking for vegetables,35140,-0.0475303966239874,0.04872284333347,-0.143027169557589,0.0479663763096139,0.329321547196777
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20740.Liking for vinegar,35140,-0.0853988219295644,0.0420398545703054,-0.167796936887363,-0.0030007069717659,0.042241410620012
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20741.Liking for watching television,35140,-0.0288823633771956,0.042145920859293,-0.11148836826141,0.0537236415070187,0.493173042090418
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20742.Liking for whisky,35140,0.0502243768865365,0.0447217864680639,-0.0374303245908688,0.137879078363942,0.261445546235448
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20743.Liking for white bread,35140,-0.0454445156832615,0.0419641203437576,-0.127694191557026,0.0368051601905033,0.278860657443154
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20744.Liking for white rice,35140,0.0154431971865887,0.0419673043455065,-0.066812719330604,0.0976991137037814,0.712894222725208
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20745.Liking for white wine,35140,0.103743280614453,0.0420817145516032,0.0212631200933102,0.186223441135595,0.013706169123516
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35140,0.0697568858054079,0.0425565238565174,-0.0136539009533663,0.153167672564182,0.101209720518211
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20747.Liking for whole milk,35140,0.0231198658453744,0.0421715924934507,-0.0595364554417889,0.105776187132538,0.583543268474632
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20748.Liking for wholemeal bread,35140,0.0261615450135028,0.0447431787101467,-0.0615350852583846,0.11385817528539,0.55875867385739
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20749.Liking for working up a sweat,35140,0.145495158207112,0.0423176623907142,0.0625525399213125,0.228437776492912,0.000587902732705617
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21001.Body mass index (BMI),52404,-0.0628177671379324,0.00968727146990177,-0.0818048192189399,-0.0438307150569249,9.04709072621257e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21002.Weight,52412,0.0392918900937483,0.00598152350606339,0.0275681040218641,0.0510156761656326,5.15858126607956e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21021.Pulse wave Arterial Stiffness index,33685,-0.00186931294764992,0.00430311200789248,-0.0103034124831192,0.00656478658781933,0.664001216042878
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34544,-0.0978722444370043,0.0444121601216623,-0.184920078275462,-0.0108244105985463,0.0275661109049058
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34559,0.0407377511892311,0.0456309713042394,-0.048698952567078,0.13017445494554,0.372004094213798
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34560,0.0262872820732071,0.0458667764136759,-0.0636115996975977,0.116186163844012,0.566574499174684
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21040.Satisfaction with bowel habits,34510,-0.141065161374255,0.0427857917013084,-0.22492531310882,-0.0572050096396907,0.00098059307142582
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34491,-0.175857668570191,0.0446426697274997,-0.263357301236091,-0.088358035904292,8.22979463064729e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21042.Greatest number of times bowels opened per day,34504,0.0295145354726649,0.046004405879175,-0.0606541000505181,0.119683170995848,0.521174263582883
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21043.Least number of times bowels opened per week,34412,0.0513174153719556,0.0454332178070189,-0.0377316915298015,0.140366522273713,0.258708644724665
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21044.Average number of times bowels opened per day,34464,-0.0478765023629267,0.0518892459275664,-0.149579424380957,0.0538264196551035,0.356202944495006
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34563,0.108843425168344,0.0464055069406311,0.0178886315647074,0.199798218771982,0.019021561850134
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34557,0.140089092619475,0.0468142564351404,0.0483331500065993,0.23184503523235,0.00277421123616079
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34560,-0.077719653248993,0.0543595797791461,-0.184264429616119,0.0288251231181333,0.152824745538201
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34560,-0.0168359922766463,0.0485623903453725,-0.112018277353576,0.0783462928002839,0.72883303211778
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34557,0.0797159575776282,0.0716326105836662,-0.0606839591663575,0.220115874321614,0.265801689230941
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34558,0.134666775346554,0.0528040707781745,0.0311707966213316,0.238162754071776,0.0107773241864232
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34558,-0.17505453064777,0.134525184913909,-0.438723893079032,0.0886148317834919,0.193193321070891
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34562,0.0156736336050924,0.0504372104435688,-0.0831832988643024,0.114530566074487,0.755993013291183
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34561,0.136587983440566,0.0531697626098591,0.0323752487252423,0.24080071815589,0.0102163077205133
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34293,-0.023597315708023,0.0475784300234168,-0.11685103855392,0.0696564071378739,0.619929001844599
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34558,0.0331656552730767,0.0475092333202672,-0.0599524420346469,0.1262837525808,0.485137835688863
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34560,0.139247991971853,0.0622780071330531,0.0171830979910691,0.261312885952637,0.0253794365685804
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34562,0.109055681571915,0.0463660969638615,0.0181781315227464,0.199933231621084,0.0186890113797885
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34560,0.0678851600924367,0.0464518888093665,-0.0231605419739216,0.158930862158795,0.143934605293172
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X21100.Water hardness (USGS classification),52267,0.00193149219552113,0.0274485088020885,-0.0518675850565723,0.0557305694476146,0.943901395971846
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2139.Age first had sexual intercourse,48555,0.0137598604896811,0.00307108931061742,0.00774052544087098,0.0197791955384913,7.48284164338762e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2149.Lifetime number of sexual partners,47015,0.0103261318975761,0.0308524756764948,-0.0501447204283536,0.0707969842235059,0.737859200539536
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22032.IPAQ activity group,46076,0.0696043491740445,0.0311014924226566,0.00864542402563757,0.130563274322451,0.0252328530758317
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22033.Summed days activity,46767,0.00733554659492178,0.00290178718894807,0.00164804370458356,0.01302304948526,0.011480206145997
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22034.Summed minutes activity,46076,0.00855820494113021,0.00292217186881502,0.00283074807825277,0.0142856618040076,0.00340722880079971
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22037.MET minutes per week for walking,45023,0.00978352688838342,0.00297034784991338,0.0039616451025532,0.0156054086742136,0.000990339500491982
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22038.MET minutes per week for moderate activity,46076,0.00478942289934846,0.00288432913401655,-0.000863862203323983,0.0104427080020209,0.0968287985299119
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22039.MET minutes per week for vigorous activity,46076,0.0459882112314699,0.0311182677035063,-0.0150035934674025,0.106980015930342,0.139461814581797
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22040.Summed MET minutes per week for all activity,45023,0.00827503227788603,0.00302416515103967,0.00234766858184828,0.0142023959739238,0.00621870864894459
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X2217.Age started wearing glasses or contact lenses,48577,0.00553517495154338,0.00276681367352851,0.000112220151427494,0.0109581297516593,0.0454510841493704
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X22501.Year ended full time education,31431,0.0298405301648978,0.0129939682146455,0.00437235246419274,0.0553087078656029,0.0216773099834943
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X22506.Tobacco smoking,31387,0.427719319404612,0.112498053681652,0.207223134188574,0.64821550462065,0.000144755239122911
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50599,-0.0590972532094553,0.0647790777424705,-0.186064245584697,0.0678697391657868,0.361624907880679
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23098.Weight,51982,0.0399372600578037,0.00602616375719307,0.0281259790937053,0.0517485410219021,3.48167064229228e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23099.Body fat percentage,51983,0.0159206416043849,0.00618701261208501,0.00379409688469828,0.0280471863240715,0.0100804426212593
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23100.Whole body fat mass,51975,0.025227361536307,0.00592821700096362,0.0136080562144183,0.0368466668581957,2.09298020082663e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23101.Whole body fat-free mass,51982,0.0220438090116684,0.00496159378212845,0.0123190851986967,0.0317685328246402,8.91048991130288e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23102.Whole body water mass,51982,0.0211927290564589,0.00497907819903272,0.0114337357863548,0.030951722326563,2.08473029487326e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23104.Body mass index (BMI),51982,-0.0658684711781395,0.00981106066600042,-0.0850981500835003,-0.0466387922727787,1.93442597507771e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23105.Basal metabolic rate,51980,0.0262740828129418,0.00540860661789629,0.0156732138418651,0.0368749517840185,1.19331905553864e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23106.Impedance of whole body,51976,0.00936615494653371,0.00405415841724056,0.00142000444874222,0.0173123054443252,0.0208811916434841
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23107.Impedance of leg (right),51979,-0.00728051898569681,0.00332060169557537,-0.0137888983090245,-0.000772139662369087,0.0283495963740015
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23108.Impedance of leg (left),51978,-0.00799312692028973,0.00328696247088621,-0.0144355733632267,-0.00155068047735277,0.0150317029974696
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23109.Impedance of arm (right),51969,0.0201165291565653,0.00406005598671863,0.0121588194225968,0.0280742388905338,7.28557964753979e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23110.Impedance of arm (left),51977,0.0202110843563411,0.00407247882224974,0.0122290258647316,0.0281931428479506,6.9882087310259e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23111.Leg fat percentage (right),51978,-0.0340262612521408,0.00976952872540715,-0.0531745375539388,-0.0148779849503428,0.000496789297519709
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23112.Leg fat mass (right),51977,0.0245005194740186,0.0112202960456219,0.00250873922459975,0.0464922997234375,0.0290008473108359
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23113.Leg fat-free mass (right),51977,0.0344177540891793,0.00503843803849851,0.0245424155337223,0.0442930926446364,8.60574098031441e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23114.Leg predicted mass (right),51976,0.0350223766228142,0.00505740684384243,0.025109859208883,0.0449348940367453,4.4565456873185e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23115.Leg fat percentage (left),51973,-0.0375382207050984,0.0100780872762826,-0.0572912717666124,-0.0177851696435844,0.00019590954402859
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23116.Leg fat mass (left),51973,0.0183802392534151,0.0112655065548709,-0.00370015359413181,0.0404606321009621,0.102785722278828
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23117.Leg fat-free mass (left),51971,0.0361615525930493,0.0051668686028969,0.0260344901313714,0.0462886150547273,2.64198182968549e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23118.Leg predicted mass (left),51970,0.0362661574562551,0.00518645155655464,0.026100712405408,0.0464316025071022,2.76235269428882e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23119.Arm fat percentage (right),51970,0.00355404759081625,0.00687974366708179,-0.00993024999666405,0.0170383451782966,0.605442407515445
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23120.Arm fat mass (right),51967,0.00323288222608499,0.00619253764158594,-0.00890449155142345,0.0153702560035934,0.601632080921135
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23121.Arm fat-free mass (right),51968,0.0117026285959396,0.00482709744192344,0.00224151760976967,0.0211637395821095,0.0153417351844767
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23122.Arm predicted mass (right),51967,0.0109314035950395,0.0048235806887413,0.00147718544510651,0.0203856217449724,0.023444271072946
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23123.Arm fat percentage (left),51964,0.00491244852275608,0.00771080339029447,-0.0102007261222211,0.0200256231677332,0.524073821353081
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23124.Arm fat mass (left),51963,0.00498701043945619,0.0063516668753794,-0.00746225663628743,0.0174362775151998,0.432372462807739
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23125.Arm fat-free mass (left),51963,0.0128337129383776,0.00520041020239828,0.00264090894167692,0.0230265169350782,0.0135996365682818
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23126.Arm predicted mass (left),51961,0.0133467378008877,0.00520895000544425,0.00313719579021692,0.0235562798115584,0.0104043111906762
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23127.Trunk fat percentage,51959,0.0149341927256406,0.0039096993386022,0.00727118202198026,0.0225972034293009,0.000133863878501002
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23128.Trunk fat mass,51955,0.0259046897650793,0.00450471552828244,0.0170754473296458,0.0347339322005129,8.98833049535086e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23129.Trunk fat-free mass,51949,0.0146246705137195,0.00463365992627489,0.00554269705822071,0.0237066439692183,0.00160021948123892
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23130.Trunk predicted mass,51946,0.0139798711116293,0.00464122164855826,0.00488307668045516,0.0230766655428035,0.00259674236781048
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23400.Total Cholesterol,40516,0.0153277604275947,0.0034485472846249,0.00856860774972995,0.0220869131054595,8.86035432897923e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40516,0.0187399985088229,0.00333609226802592,0.0122012576634921,0.0252787393541537,1.97123221736184e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40516,0.0209740668301864,0.00333076203067371,0.0144457732500659,0.0275023604103069,3.11190087925618e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23403.VLDL Cholesterol,40516,0.0225873633925249,0.00326592461471617,0.0161861511476812,0.0289885756373685,4.81851673320277e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23404.Clinical LDL Cholesterol,40516,0.0154946730666888,0.00333880815518187,0.00895060908253235,0.0220387370508453,3.49839716163599e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23405.LDL Cholesterol,40516,0.0160239417762776,0.00333821278585429,0.00948104471600314,0.022566838836552,1.5996904251294e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23406.HDL Cholesterol,40516,-0.00598865264607287,0.00384599676916517,-0.0135268063136366,0.00154950102149087,0.119463292055514
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23407.Total Triglycerides,40516,0.0161648532714702,0.00353550583044039,0.00923526184380702,0.0230944446991333,4.86353661009433e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23408.Triglycerides in VLDL,40516,0.0166873191621865,0.00353710421248638,0.00975459490571318,0.0236200434186598,2.40426191867789e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23409.Triglycerides in LDL,40516,0.0101684864840594,0.00352449318581542,0.0032604798398612,0.0170764931282576,0.00391820033848503
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23410.Triglycerides in HDL,40516,0.011679359855875,0.00333331329090661,0.005146065805698,0.0182126539060519,0.000459867559123496
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40516,0.0107410168484422,0.0035153972299122,0.00385083827781429,0.0176311954190701,0.00225113650490427
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23412.Phospholipids in VLDL,40516,0.0210192394332259,0.00336357728734285,0.0144266279500339,0.0276118509164179,4.23304649219564e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23413.Phospholipids in LDL,40516,0.0147297607236627,0.00331408155633315,0.00823416087324975,0.0212253605740757,8.86457544327042e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23414.Phospholipids in HDL,40516,-0.0061941080308047,0.00373235600566289,-0.013509525801904,0.00112130974029457,0.0970204008823268
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23415.Total Esterified Cholesterol,40516,0.01389386513088,0.00345997524669119,0.00711231364736522,0.0206754166143947,5.95651131434906e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40516,0.0230430920491874,0.003246159332657,0.0166806197571796,0.0294055643411951,1.31327296244202e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40516,0.0165288686818235,0.00333160898327334,0.00999891507460772,0.0230588222890392,7.07654723807609e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40516,-0.00731903825981517,0.00381951950166759,-0.0148052964830836,0.000167219963453302,0.0553548721161769
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23419.Total Free Cholesterol,40516,0.0186260686155096,0.00341855003567122,0.011925710545594,0.0253264266854252,5.15355691012438e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23420.Free Cholesterol in VLDL,40516,0.02164254129127,0.00332445489386732,0.0151266096992901,0.02815847288325,7.73255915675357e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23421.Free Cholesterol in LDL,40516,0.014168335810326,0.00336556547289276,0.00757182748345622,0.0207648441371959,2.56994588228032e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23422.Free Cholesterol in HDL,40516,-0.00113098788041765,0.00386348368350427,-0.00870341590008602,0.00644144013925071,0.769726322683515
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40516,0.0165955395019839,0.00343582295845064,0.00986132650342068,0.0233297525005472,1.37688141095314e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23424.Total Lipids in VLDL,40516,0.0207413547084958,0.00343167978495781,0.0140152623299785,0.0274674470870132,1.53583834368847e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23425.Total Lipids in LDL,40516,0.0157926020794199,0.00333179870112833,0.00926227662520837,0.0223229275336314,2.15589804311532e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23426.Total Lipids in HDL,40516,-0.00480113063705262,0.00377709483042965,-0.0122042365046947,0.00260197523058949,0.203705321939312
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40516,-0.00281914862086583,0.00353513975605969,-0.00974802254274283,0.00410972530101116,0.42519307271039
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23428.Concentration of VLDL Particles,40516,0.021080101462904,0.00331383654264094,0.0145849818393278,0.0275752210864803,2.0554719788118e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23429.Concentration of LDL Particles,40516,0.0203351517076883,0.00330379320988265,0.0138597170163183,0.0268105863990582,7.68154807714012e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23430.Concentration of HDL Particles,40516,-0.00635558848651837,0.00354225682019014,-0.013298411854091,0.000587234881054313,0.0727968377548543
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40516,0.0156800783290474,0.00373023338752719,0.00836882088949409,0.0229913357686007,2.64227486967868e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23432.Average Diameter for LDL Particles,40516,-0.00847611778903661,0.00341874232745356,-0.0151768527508456,-0.00177538282722764,0.0131739100051061
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23433.Average Diameter for HDL Particles,40516,0.00545088074798868,0.00403767494391458,-0.0024629621420839,0.0133647236380613,0.177033449043144
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23434.Phosphoglycerides,40502,0.00597608215724329,0.00353282228471726,-0.000948249520802537,0.0129004138352891,0.0907438407668408
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40502,0.0157006670541263,0.00374014895263416,0.00836997510696334,0.0230313590012892,2.70885870112715e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23436.Total Cholines,40502,0.00731633313713932,0.0035404838784041,0.000376984735467288,0.0142556815388113,0.0387993414584628
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23437.Phosphatidylcholines,40502,0.00741974154041316,0.00354239658041456,0.000476644242800622,0.0143628388380257,0.0362262818761471
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23438.Sphingomyelins,40501,0.00768345171167629,0.00355997545264227,0.000705899824497436,0.0146610035988551,0.030920241802353
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23439.Apolipoprotein B,40516,0.0205523874167676,0.0033024971677226,0.0140794929680313,0.0270252818655039,4.98919501277462e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23440.Apolipoprotein A1,40516,-0.00518612327783426,0.00366153977645979,-0.0123627412396954,0.00199049468402693,0.156684340330376
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40516,0.0199961081320558,0.00333185690091531,0.0134656686062618,0.0265265476578498,1.99716568778868e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23442.Total Fatty Acids,40502,0.0128745148979383,0.00354115190887618,0.00593385715654102,0.0198151726393356,0.000278109263462001
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23443.Degree of Unsaturation,40502,-0.00753558855568361,0.00371137253846399,-0.014809878731073,-0.000261298380294193,0.0423318654989541
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23444.Omega-3 Fatty Acids,40502,0.00761166409996004,0.00346721888212608,0.000815915090992925,0.0144074131089271,0.0281547276110212
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23445.Omega-6 Fatty Acids,40502,0.0121030050963119,0.00342005230292759,0.00539970258257386,0.01880630761005,0.000403030934810144
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40502,0.0119007890989353,0.00345049616398059,0.00513781661753337,0.0186637615803373,0.000564094614169517
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40502,0.0129107290285744,0.00363535950679868,0.005785424395249,0.0200360336618998,0.000384239561138597
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23448.Saturated Fatty Acids,40502,0.011835903105635,0.00361700814839694,0.00474656713477698,0.018925239076493,0.00106905054061032
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23449.Linoleic Acid,40502,0.0162992844969523,0.00338544233785827,0.00966381751475009,0.0229347514791545,1.48897667185933e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23450.Docosahexaenoic Acid,40502,0.00150996665351394,0.00364588228346576,-0.00563596262207895,0.00865589592910683,0.678764869125397
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40502,0.00234302017781483,0.00346367567764173,-0.00444578415036297,0.00913182450599263,0.498761656712931
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40502,-0.00548981292335572,0.00386993348663171,-0.0130748825571539,0.00209525671044243,0.156040715177352
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40502,-0.0062511676442538,0.00388826598770427,-0.0138721689801542,0.00136983369164656,0.107920432200966
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40502,0.00836590026543868,0.00382822023745485,0.000862588600027173,0.0158692119308502,0.0288795293078698
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40502,0.000513324826857228,0.00361104726534756,-0.00656432781322398,0.00759097746693844,0.886960146621154
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40502,0.0102835885912712,0.00371790896313963,0.00299648702351754,0.0175706901590249,0.00568203247581176
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40502,-0.00635373126305875,0.00369343937921196,-0.0135928724463142,0.000885409920196692,0.0854017494713597
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40502,-0.00786819533410151,0.00387062876483973,-0.0154546277131874,-0.000281762955015643,0.0420896498883742
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40500,-0.00354923974720219,0.00344819951240723,-0.0103077107915204,0.00320923129711599,0.303353147699101
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23460.Alanine,40509,0.00418367620140044,0.00330186917756026,-0.00228798738661768,0.0106553397894186,0.205151147933038
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23461.Glutamine,40468,0.0214878700874488,0.0033301110759378,0.0149608523786108,0.0280148877962869,1.13104059292439e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23462.Glycine,40495,0.0338651558044835,0.00318073254150098,0.0276309200231416,0.0400993915858254,2.20640418060023e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23463.Histidine,40496,-0.00680783069983433,0.00325691194215151,-0.0131913781064513,-0.000424283293217369,0.0366091056740073
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40505,0.00291342100693284,0.00332539244948702,-0.00360434819406173,0.00943119020792741,0.380981478161317
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23465.Isoleucine,40512,0.00125104534103434,0.00326178770519243,-0.00514205856114282,0.00764414924321149,0.701320112031109
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23466.Leucine,40513,0.00512898477921378,0.00332457265540236,-0.00138717762537485,0.0116451471838024,0.122911123651408
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23467.Valine,40505,0.00160237990767596,0.00335398203694218,-0.00497142488473071,0.00817618470008263,0.632831476020063
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23468.Phenylalanine,40513,-0.00137067852729563,0.00324686123652889,-0.00773452655089225,0.00499316949630099,0.67291757572151
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23469.Tyrosine,40497,0.0110786886108361,0.00326673483426171,0.00467588833568316,0.0174814888859891,0.000697133045007051
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23470.Glucose,40484,-0.0189927126199072,0.00345093376833522,-0.0257565428058442,-0.0122288824339701,3.77725053528573e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23471.Lactate,40484,0.00960364330536922,0.0032366209898616,0.00325986616524049,0.015947420445498,0.00300986691483961
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23472.Pyruvate,40469,0.000294149931455521,0.00334992343332185,-0.00627169999785531,0.00685999986076635,0.930030411458649
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23473.Citrate,40514,0.00627238309016482,0.00332236795083209,-0.000239458093466062,0.0127842242737957,0.0590539643703984
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23474.3-Hydroxybutyrate,40311,-0.0176021421792371,0.00312486758544694,-0.0237268826467131,-0.0114774017117611,1.80187703877206e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23475.Acetate,40502,-0.00144151190578538,0.00337127881178465,-0.0080492183768833,0.00516619456531254,0.668958235641589
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23476.Acetoacetate,40515,-0.0213706569419913,0.00323488898448614,-0.0277110393515841,-0.0150302745323985,4.06415752766068e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23477.Acetone,40515,-0.0118229531335585,0.00325247901140692,-0.0181978119959161,-0.00544809427120093,0.000278784791969497
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23478.Creatinine,40029,0.00779484075804325,0.00383969627409264,0.000269036060821684,0.0153206454552648,0.0423666863110338
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23479.Albumin,40515,0.00196105234778289,0.00336556082913909,-0.00463544687732972,0.00855755157289549,0.560115445217423
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23480.Glycoprotein Acetyls,40516,-0.0106295783300311,0.00357912071728697,-0.0176446549359136,-0.00361450172414864,0.00298351191711925
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40516,0.0150584300057802,0.00357083826630621,0.00805958700382003,0.0220572730077404,2.48866260889916e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40516,0.0140967759929488,0.00357269883766361,0.0070942862711281,0.0210992657147695,7.9907608329146e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40516,0.0126586249500506,0.00351621241299065,0.00576684862058897,0.0195504012795123,0.000319084513643375
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40516,0.0163363515970934,0.00351091552488864,0.00945495716831164,0.0232177460258751,3.29723475070038e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40516,0.0183585337494581,0.00348926753647382,0.0115195693779694,0.0251974981209468,1.44775805075582e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40516,0.0136260969263462,0.00352921410385639,0.0067088372827877,0.0205433565699048,0.000113392424505461
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40516,0.0148594944535144,0.00359728150297865,0.00780882270767624,0.0219101661993526,3.63401102775094e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40516,0.017142704284784,0.00350356025657809,0.010275726181891,0.0240096823876771,1.00304240755179e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40516,0.0177963862803691,0.00351165311307889,0.0109135461787345,0.0246792263820038,4.0688931808657e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40516,0.0188816779801489,0.00348021289496345,0.0120604607060206,0.0257028952542773,5.86495366171316e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40516,0.0212305676243031,0.00338239246729712,0.0146010783884007,0.0278600568602054,3.54500550656015e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40516,0.0217863258992257,0.00331369068417994,0.015291492158233,0.0282811596402184,5.02740081326642e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40516,0.0197352498142727,0.00345564228346673,0.0129621909386779,0.0265083086898675,1.14286105473963e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40516,0.0148596065661772,0.00355393987588796,0.00789388440943684,0.0218253287229177,2.91557346381644e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40516,0.0187997029957437,0.00347074227590276,0.0119970481349743,0.0256023578565131,6.16087223372912e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23496.Total Lipids in Large VLDL,40516,0.0191562989817964,0.00346434640500532,0.012366180027986,0.0259464179356068,3.2604646961514e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23497.Phospholipids in Large VLDL,40516,0.018321186649345,0.0034457465332173,0.0115675234442391,0.0250748498544509,1.06877560908007e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23498.Cholesterol in Large VLDL,40516,0.0202964495502744,0.00334809198508972,0.0137341892594986,0.0268587098410503,1.37364830662863e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40516,0.0214328858497997,0.00326796969401896,0.0150276652495225,0.0278381064500769,5.60214078681326e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40516,0.0185496795562796,0.00343421279299009,0.011818622482019,0.0252807366305401,6.7050147706283e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23501.Triglycerides in Large VLDL,40516,0.0181388770664117,0.00351874248209634,0.0112421418015029,0.0250356123313205,2.56733019756065e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40516,0.0220260700919366,0.00329319041838196,0.0155714168719079,0.0284807233119652,2.33118981370977e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40516,0.0217181384957138,0.00332821158439234,0.0151948437903048,0.0282414332011228,6.98176164268099e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40516,0.0223603418412283,0.00328450976968119,0.0159227026926532,0.0287979809898034,1.0259891483904e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40516,0.02184322262249,0.00330789001685685,0.0153597581894506,0.0283266870555295,4.14518325608151e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40516,0.0203544652945127,0.00336413061246378,0.0137607692940837,0.0269481612949417,1.47657884877956e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40516,0.0223145991433833,0.00327561395304583,0.0158943957954135,0.0287348024913531,9.94317859022709e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40516,0.0180122057607233,0.00345338254780813,0.0112435759670193,0.0247808355544272,1.85282558053788e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40516,0.0186951221445791,0.00331767283351485,0.01219248339089,0.0251977608982682,1.77985596351017e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23510.Total Lipids in Small VLDL,40516,0.0183442396855698,0.00329975522004546,0.0118767194542807,0.0248117599168589,2.75213567393321e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23511.Phospholipids in Small VLDL,40516,0.0192843224909453,0.0032605360335134,0.012893671865259,0.0256749731166316,3.39715447503649e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23512.Cholesterol in Small VLDL,40516,0.0199730521458997,0.00322329053031112,0.0136554027064899,0.0262907015853094,5.91479652879603e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40516,0.0195307744651585,0.00320458033519625,0.0132497970081738,0.0258117519221431,1.12186591145678e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40516,0.0201720084826278,0.00326561025368817,0.013771412385399,0.0265726045798566,6.68610171998623e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23515.Triglycerides in Small VLDL,40516,0.0128017464952811,0.00342242599414003,0.00609379154676663,0.0195097014437955,0.000184258302923171
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40516,0.0201535067974211,0.00333789786568394,0.0136112269806806,0.0266957866141617,1.59683882196692e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40516,0.0194756108245526,0.00333629227137096,0.0129364779726656,0.0260147436764397,5.40108916726124e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40516,0.0182704221351205,0.0033304909402034,0.0117426598923218,0.0247981843779192,4.17812519518398e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40516,0.0210089477375893,0.00339497261775043,0.0143548014067985,0.0276630940683802,6.23102706219664e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40516,0.021251716217913,0.00341952824253238,0.0145494408625496,0.0279539915732765,5.2654531866063e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40516,0.0196187110885305,0.00334505059750272,0.0130624119174252,0.0261750102596359,4.57960374811092e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40516,0.0104858661017716,0.00339826799021636,0.00382526084094756,0.0171464713625957,0.00203452901958075
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23523.Concentration of IDL Particles,40516,0.0183641303854377,0.00334835587169866,0.0118013528769083,0.0249269078939671,4.20849803165016e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23524.Total Lipids in IDL,40516,0.0162792884776905,0.00343990764496906,0.00953706949355109,0.0230215074618298,2.23684714087172e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23525.Phospholipids in IDL,40516,0.0180912383835632,0.00345031157751831,0.0113286276916273,0.0248538490754991,1.59673448825806e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23526.Cholesterol in IDL,40516,0.0152321009971089,0.00344342775938683,0.00848298258871069,0.0219812194055071,9.77400664285466e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40516,0.0150156441035225,0.00343507280983003,0.00828290139625562,0.0217483868107893,1.24299559813641e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23528.Free Cholesterol in IDL,40516,0.0153380761493731,0.00346325073692624,0.00855010470499765,0.0221260475937485,9.53805733869882e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23529.Triglycerides in IDL,40516,0.0100869744961902,0.00344700986929327,0.0033308351523754,0.016843113840005,0.0034350376143275
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23530.Concentration of Large LDL Particles,40516,0.0190143132203891,0.00331952074984022,0.0125080525507023,0.025520573890076,1.03422201219305e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23531.Total Lipids in Large LDL,40516,0.0153253290845276,0.00335779234751791,0.00874405608339248,0.0219066020856627,5.05338739872699e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23532.Phospholipids in Large LDL,40516,0.0147264862747588,0.00334182812782703,0.00817650314421785,0.0212764694052998,1.05629692318144e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23533.Cholesterol in Large LDL,40516,0.0155136674077382,0.00336748229227503,0.00891340211487916,0.0221139327005973,4.11848489677784e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40516,0.0155821562869708,0.00335395024358311,0.00900841380954791,0.0221558987643937,3.41264773305301e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40516,0.014855098732922,0.00340148201020285,0.00818819399292442,0.0215220034729196,1.26612179123156e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23536.Triglycerides in Large LDL,40516,0.00845489317095413,0.00349636638778285,0.00160201505089974,0.0153077712910085,0.0156087954312466
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40516,0.0202489503181116,0.00329751187329136,0.0137858270464605,0.0267120735897627,8.41044491268848e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23538.Total Lipids in Medium LDL,40516,0.0156838308899272,0.00331242231020087,0.00919148316193353,0.0221761786179209,2.21085900720011e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23539.Phospholipids in Medium LDL,40516,0.0141241677124154,0.00328900476633894,0.00767771837039106,0.0205706170544397,1.76226861765835e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23540.Cholesterol in Medium LDL,40516,0.0160980736583055,0.0033121699892691,0.00960622047933806,0.0225899268372729,1.18326753039674e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40516,0.0169967545501322,0.00332352482780837,0.0104826458876278,0.0235108632126366,3.1890843055693e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40516,0.012878448535836,0.00331401837581592,0.00638297251923677,0.0193739245524352,0.00010229663974803
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23543.Triglycerides in Medium LDL,40516,0.0111161010793247,0.00354770472803882,0.00416259981236863,0.0180696023462808,0.00173150560955074
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23544.Concentration of Small LDL Particles,40516,0.0234212754242263,0.00328519969464126,0.0169822840227294,0.0298602668257231,1.05151357289267e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23545.Total Lipids in Small LDL,40516,0.0175325962705187,0.00331635176091646,0.0110325468191224,0.0240326457219149,1.26164080873034e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23546.Phospholipids in Small LDL,40516,0.0144448544511015,0.00329905393572377,0.00797870873708295,0.0209110001651201,1.20263145228166e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23547.Cholesterol in Small LDL,40516,0.0178005674921033,0.0033077455517684,0.0113173862106373,0.0242837487735694,7.49117289567132e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40516,0.0193833873743743,0.00332873214509944,0.0128590723699793,0.0259077023787692,5.88848816282278e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40516,0.0123119459876833,0.00329119978386305,0.00586119441131174,0.0187626975640549,0.000184023117210486
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23550.Triglycerides in Small LDL,40516,0.01608856939751,0.0035755047235445,0.00908058013936274,0.0230965586556572,6.85386277338164e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40516,0.0129434719201353,0.00383113251036976,0.0054344521998106,0.0204524916404601,0.000730562205397415
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40516,0.00856713644654308,0.00385744404516702,0.00100654611801572,0.0161277267750704,0.0263691860847191
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40516,0.00717682897368454,0.00386095395626159,-0.000390640780588181,0.0147442987279573,0.0630705440474068
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40516,0.00775763432476787,0.00383135829400324,0.000248172068521518,0.0152670965810142,0.0429070940108074
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40516,0.00691444883866215,0.00389334776337938,-0.000716512777561427,0.0145454104548857,0.0757576334551864
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40516,0.00967158379547737,0.00356992969549939,0.00267452159229858,0.0166686459986562,0.00675211446440122
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40516,0.021626670112221,0.00345647666748799,0.0148519758439445,0.0284013643804974,4.02771662767907e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23558.Concentration of Large HDL Particles,40516,0.0031066997396458,0.00405931814267938,-0.00484956382000578,0.0110629632992974,0.444088979124635
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23559.Total Lipids in Large HDL,40516,0.000373570446362129,0.00403845391973917,-0.00754179923632664,0.0082889401290509,0.926299297011019
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23560.Phospholipids in Large HDL,40516,-0.00230163604098731,0.00398669434410028,-0.0101155569554239,0.00551228487344924,0.563725015886074
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23561.Cholesterol in Large HDL,40516,0.000930307238782298,0.00403698397354561,-0.00698218134936709,0.00884279582693169,0.817748071729857
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40516,0.000593293126464914,0.00402575067687706,-0.00729717820021412,0.00848376445314395,0.882838255171901
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40516,0.00194563813768827,0.0040319674724123,-0.00595701810823984,0.00984829438361638,0.629419708759618
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23564.Triglycerides in Large HDL,40516,0.0160612709728454,0.00341850409140833,0.00936100295368509,0.0227615389920057,2.64466694830238e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40516,-0.00798857561117914,0.00363082598658221,-0.0151049945448803,-0.000872156677478001,0.0278062622090712
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23566.Total Lipids in Medium HDL,40516,-0.00937781270145354,0.00359882218680652,-0.0164315041875943,-0.00232412121531275,0.00917443808249016
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23567.Phospholipids in Medium HDL,40516,-0.00942528593758569,0.00357659840896592,-0.0164354188191589,-0.0024151530560125,0.00841522511021471
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23568.Cholesterol in Medium HDL,40516,-0.0115200677149564,0.00364155562038125,-0.0186575167309036,-0.0043826186990091,0.00156173776204886
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40516,-0.0125028912148645,0.00362301645483192,-0.019604003466335,-0.00540177896339391,0.000560028800168399
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40516,-0.00713487244529995,0.00368908734773673,-0.0143654836468639,9.57387562640286e-05,0.0531247539805912
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23571.Triglycerides in Medium HDL,40516,0.00895890453298017,0.00330303752824451,0.00248495097762092,0.0154328580883394,0.00668845853599901
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23572.Concentration of Small HDL Particles,40516,-0.00610317732102758,0.00327055913179063,-0.0125134732193372,0.000307118577282049,0.0620461444949193
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23573.Total Lipids in Small HDL,40516,-0.00672905721466281,0.00330576745579766,-0.0132083614280262,-0.000249753001299396,0.0418118710078364
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23574.Phospholipids in Small HDL,40516,-0.00775090094200727,0.0033404583494239,-0.0142981993068781,-0.00120360257713642,0.0203365433396301
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23575.Cholesterol in Small HDL,40516,-0.00790909684657765,0.00327691280350584,-0.0143318459414491,-0.00148634775170621,0.0158076998621526
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40516,-0.0094152778828046,0.00324009697333838,-0.0157658679505478,-0.00306468781506137,0.00366741820236842
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40516,-0.00166428866965845,0.00339756365352242,-0.00832351343056239,0.00499493609124548,0.624248378359218
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23578.Triglycerides in Small HDL,40516,0.00836585335496009,0.00340821040372744,0.00168576096365432,0.0150459457462659,0.014113980113127
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39636,-0.00824060484811324,0.00310623441097237,-0.0143288242936191,-0.0021523854026074,0.00798807771718745
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39636,0.00259223175266667,0.00325865419837491,-0.00379473047614814,0.00897919398148148,0.426340081949193
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39636,0.0067722678244194,0.00317767684231587,0.000544021213480296,0.0130005144353585,0.0330886077557067
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39636,-0.00505691583094063,0.00332089317098038,-0.0115658664460622,0.00145203478418092,0.127840147269316
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39636,-0.000182413321806411,0.00315798950233308,-0.00637207274637925,0.00600724610276643,0.953938580834019
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40274,0.014915853266186,0.00306347387877242,0.00891144446379203,0.0209202620685799,1.13284890388453e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40274,0.00579514077981282,0.00347719883877455,-0.00102016894418529,0.0126104505038109,0.0956114049657078
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40274,0.00400752219915547,0.00348556355015062,-0.00282418235913974,0.0108392267574507,0.250264763652357
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40274,0.0108756438578279,0.00329332407241933,0.00442072867588601,0.0173305590397698,0.000960976075313314
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40274,-0.0112533590549336,0.00333552087224347,-0.0177909799645308,-0.00471573814533637,0.000743178343343352
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40511,0.00815968918042848,0.00325838917667907,0.0017732463941375,0.0145461319667195,0.0122823680801732
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40511,0.00792720520618071,0.00321686543433398,0.00162214895488611,0.0142322614574753,0.0137398955360951
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40511,0.008994311822663,0.00337546122950436,0.00237840781283446,0.0156102158324915,0.00771530386152857
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40511,0.00320385440474463,0.00309461920405393,-0.00286159923520108,0.00926930804469034,0.300545152015977
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40511,-0.00974575114622628,0.00303786489376977,-0.015699966338015,-0.00379153595443752,0.00133880745611828
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40516,0.0123406426772347,0.00339820782909163,0.00568015533221511,0.0190011300222543,0.000282638802248502
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40516,0.00592498870769367,0.00355195205430659,-0.00103683731874724,0.0128868147341346,0.0953166250844636
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40516,0.00458982635321994,0.00357884239187991,-0.00242470473486469,0.0116043574413046,0.19968963227759
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40516,0.00935240496478481,0.00347342795069733,0.00254448618141805,0.0161603237481516,0.0070979805495206
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40516,-0.00763493338933842,0.00352661025713243,-0.014547089493318,-0.000722777285358851,0.0304062230018979
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40516,0.00560720216718359,0.00345721710804189,-0.00116894336457852,0.0123833476989457,0.104847995144363
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40516,0.0109734760760346,0.00338209979101147,0.00434456048565213,0.0176023916664171,0.00117866629616777
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40516,0.0119162000476586,0.00328821764666387,0.0054712934601974,0.0183611066351198,0.000291079889315142
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40516,0.00744312224300151,0.00346773042927597,0.000646370601620621,0.0142398738843824,0.0318563402913222
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40516,-0.00966660294302895,0.00341015817773759,-0.0163505129713946,-0.00298269291466328,0.00459332460781947
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40516,-0.00673216658594126,0.00347093981749129,-0.0135352086282242,7.08754563416604e-05,0.0524481971571274
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40516,0.010705284025391,0.00360302518576912,0.00364335466128357,0.0177672133894985,0.00297084229525083
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40516,0.010713686751042,0.00362586431265412,0.00360699269823997,0.0178203808038441,0.00313330525938679
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40516,0.00685898560546409,0.00351821880204204,-3.67232465383191e-05,0.0137546944574665,0.0512457251635478
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40516,-0.0103623559762048,0.00359681250149101,-0.0174121084791271,-0.00331260347328239,0.00396961555060413
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40516,0.00536053416098682,0.0032403047022904,-0.000990463055502372,0.011711531377476,0.0980799623067325
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40516,0.00226431322581329,0.00342560053029242,-0.00444986381355986,0.00897849026518644,0.508623426243184
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40516,0.00227274628336158,0.00341387334153644,-0.00441844546604984,0.00896393803277299,0.505587938262304
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40516,0.000773752457607944,0.0035217742826443,-0.00612892513637488,0.00767643005159077,0.826103472240119
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40516,-0.0067428064617266,0.0035400917176767,-0.0136813862283729,0.000195773304919723,0.0568371506197232
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40516,-0.00585954879205237,0.00322984842316222,-0.0121900517014503,0.000470954117345582,0.0696675987240833
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40516,0.0126788450605663,0.00354948687817396,0.00572185077934534,0.0196358393417872,0.000355271547748022
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40516,0.010910682210106,0.0032723856516273,0.00449680633291652,0.0173245580872955,0.000857486162064681
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40516,0.00277456836421187,0.00354090308106271,-0.00416560167467104,0.00971473840309477,0.433300215000622
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40516,-0.00989511683983582,0.00352881702846776,-0.0168115982156326,-0.00297863546403902,0.0050519531345426
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40516,-0.0148696178650452,0.0031943534299343,-0.0211305505877165,-0.00860868514237401,3.26619295186093e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40516,0.0156357835361115,0.00328966313171976,0.00918804379794076,0.0220835232742822,2.0215225735777e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40516,0.0185861975482248,0.00333203570728017,0.0120554075619557,0.025116987534494,2.47180640437809e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40516,-0.00837151600413503,0.00360891030841966,-0.0154449802086376,-0.00129805179963248,0.0203706822211251
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40516,-0.00789926694155613,0.00340986924354746,-0.0145826106589091,-0.00121592322420311,0.0205386259203722
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40516,-0.0171928198003187,0.0032611662766896,-0.0235847057026303,-0.010800933898007,1.3670291442669e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40516,0.0146712473531766,0.00330526395562422,0.00819293000015312,0.0211495647062001,9.10845951967318e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40516,0.0197629274149446,0.0032892661902942,0.013315965681968,0.0262098891479213,1.91515887164456e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40516,-0.0074161092306798,0.00353264505423878,-0.0143400935369878,-0.000492124924371793,0.0358053416152348
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40516,0.00098973276762488,0.00349155006475999,-0.00585370535930471,0.00783317089455447,0.776823944663615
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40514,-0.00110374160631512,0.00375942838459617,-0.00847222124012361,0.00626473802749336,0.769072769741504
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40514,-0.00673355747199771,0.00375167216087734,-0.0140868349073173,0.000619719963321868,0.0727019751295092
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40514,-0.00773902287640153,0.00376110833144325,-0.0151107952060303,-0.000367250546772762,0.0396404002966295
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40514,-1.65221833327912e-05,0.00398903579053306,-0.00783503233277758,0.007801987966112,0.996695303625852
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40514,0.0116907655622635,0.00374444301460235,0.0043516572536429,0.0190298738708841,0.00179845511315574
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40516,-0.0231285395035986,0.00389609486667107,-0.0307648854422739,-0.0154921935649233,2.9745835220075e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40516,0.005777050209691,0.00387557179760524,-0.00181907051361527,0.0133731709329973,0.136077849038303
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40516,0.00430717055329983,0.00391549197135956,-0.0033671937105649,0.0119815348171646,0.271334208785644
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40516,0.00958547631803902,0.00376213563402327,0.0022116904753534,0.0169592621607246,0.0108471535152217
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40516,0.0148656395712913,0.00376309002035162,0.00748998313140209,0.0222412960111804,7.8360194771745e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40516,0.00123669822764227,0.00367492112415175,-0.00596614717569515,0.00843954363097969,0.73648034280735
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40516,-0.0103000735013378,0.00358096679164518,-0.0173187684129623,-0.0032813785897132,0.00402847025963669
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40516,-0.0124775183753205,0.0035587818836891,-0.0194527308673511,-0.00550230588328985,0.000455929375693286
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40516,0.00275486243517407,0.00385340362928679,-0.00479780867822804,0.0103075335485762,0.474670933919197
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40516,0.0152554462247722,0.0034853413445879,0.00842417718937994,0.0220867152601645,1.21066457491677e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40516,-0.00681303066746111,0.0034150601452505,-0.0135065485521521,-0.000119512782770121,0.046060201372326
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40516,-0.00428469335964904,0.00341979334769977,-0.0109874883211406,0.0024181016018425,0.210256691381163
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40516,-0.00868730661622195,0.00343109797854842,-0.0154122586541769,-0.00196235457826704,0.0113530483161412
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40516,0.0156034584498253,0.00348605641303417,0.00877078788027836,0.0224361290193723,7.65908803790941e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40516,0.0135601144477415,0.00348262313779611,0.00673417309766109,0.0203860557978219,9.91466076733051e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52108,0.000888777552069944,0.00283950426103096,-0.00467665079955074,0.00645420590369063,0.754279619444313
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52108,3.75294881423851e-05,0.00278247615545406,-0.00541612377654758,0.00549118275283235,0.989238714405621
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50221,-0.00204625951278017,0.00266212844403292,-0.00726403126308469,0.00317151223752435,0.442104928128618
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50221,-0.000862219957812692,0.00289855595207651,-0.00654338962388265,0.00481894970825727,0.76611365669947
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50221,-0.00152832520226214,0.00284621185310853,-0.00710690043435486,0.00405025002983058,0.591294229091327
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50221,-0.00237160676637574,0.00260554808731243,-0.0074784810175081,0.00273526748475663,0.362718090916754
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24009.Traffic intensity on the nearest road,52108,0.0184548208694736,0.0608588367462071,-0.100828499153092,0.13773814089204,0.761709408707618
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24010.Inverse distance to the nearest road,52108,0.00367181231636215,0.00248083981775626,-0.00119063372644013,0.00853425835916443,0.13886641718614
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24011.Traffic intensity on the nearest major road,52108,-0.00460938052644131,0.00248725270454977,-0.00948439582735886,0.000265634774476239,0.0638641214912913
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24012.Inverse distance to the nearest major road,52108,0.00281646393994111,0.00252803111729975,-0.00213847704996641,0.00777140492984862,0.265248605440368
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24013.Total traffic load on major roads,52108,0.0602009646214222,0.0424536136479258,-0.0230081181285124,0.143410047371357,0.156190063412399
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24015.Sum of road length of major roads within 100m,52108,0.0482474815001647,0.0411667781190445,-0.0324394036131624,0.128934366613492,0.241206981398725
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52108,-0.000789076735657107,0.00282418471593669,-0.00632447877889303,0.00474632530757881,0.779940089196447
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52108,0.000380280066990889,0.00281779192695562,-0.00514259210984213,0.00590315224382391,0.892647044639462
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52108,0.0004287659925208,0.00279102572636014,-0.00504164443114507,0.00589917641618667,0.877908051809774
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52041,-0.00312349039188142,0.002749567480215,-0.00851264265310282,0.00226566186933997,0.255969212304965
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24020.Average daytime sound level of noise pollution,52108,0.00179383979921898,0.00249862449897414,-0.00310346421877033,0.00669114381720829,0.472805942682835
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24021.Average evening sound level of noise pollution,52108,0.00178134714980276,0.0024983830209949,-0.00311548357134723,0.00667817787095276,0.475851759114652
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24022.Average night-time sound level of noise pollution,52108,0.00178780272218746,0.00249858098225958,-0.00310941600304132,0.00668502144741625,0.474289363588739
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52108,0.0017877736614956,0.00249838797294203,-0.00310906676547078,0.00668461408846198,0.474262405548023
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52108,0.00179094353706892,0.00249837694552907,-0.00310587527616804,0.00668776235030589,0.473477150063141
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49133,-0.00150674319741633,0.00290988005796564,-0.00721010811102897,0.00419662171619632,0.604600708061348
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49133,0.00208438569097967,0.00265449711283808,-0.00311842865018297,0.00728720003214231,0.43232738760356
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24502.Water percentage, buffer 1000m",49133,0.00196223237902587,0.00260451298862286,-0.00314261307867493,0.00706707783672668,0.451218546898589
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49133,-0.00180090919825561,0.00274249121842471,-0.00717619198636805,0.00357437358985682,0.511399839482511
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49133,0.000876214354690264,0.0026738356536979,-0.00436450352655761,0.00611693223593814,0.743141732304136
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24505.Water percentage, buffer 300m",49133,0.000829770842388553,0.00261809557979795,-0.00430169649401543,0.00596123817879254,0.751294236577672
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52267,-0.00342431074746502,0.00277779909388853,-0.00886879697148654,0.00202017547655651,0.217682302824515
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52267,-0.00469924865911877,0.00261878785208643,-0.00983207284920817,0.000433575530970635,0.0727543711991068
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24508.Distance (Euclidean) to coast,52267,0.00125675802467738,0.00250461258202015,-0.00365228263608211,0.00616579868543687,0.615828073921197
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35753,-0.0347185759332254,0.0452722412416709,-0.1234521687669,0.0540150169004497,0.443166265978878
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2704.Years since last cervical smear test,45738,0.0862435243900178,0.0325861584750504,0.0223746537789191,0.150112395001117,0.00813579276320362
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2714.Age when periods started (menarche),51597,0.0654414160819395,0.0276093895566344,0.0113270125509361,0.119555819612943,0.0177825545080273
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2734.Number of live births,52439,-0.0186163709710198,0.0265410969585014,-0.0706369210096826,0.0334041790676431,0.483048782084457
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2744.Birth weight of first child,46645,0.104918212732364,0.029714584454679,0.0466776272011934,0.163158798263535,0.000415041345873114
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2754.Age at first live birth,43353,0.00851813153285531,0.00316118955159497,0.00232220001172916,0.0147140630539815,0.00705361106286201
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2764.Age at last live birth,43299,0.00686953770034577,0.00305522375139542,0.000881299147610744,0.0128577762530808,0.0245586014432288
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2794.Age started oral contraceptive pill,45927,0.000674732791121509,0.00344848423849036,-0.0060842963163196,0.00743376189856262,0.844877608936738
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2804.Age when last used oral contraceptive pill,43927,-0.0177323240612383,0.00296742032301652,-0.0235484678943507,-0.0119161802281259,2.33134697213781e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2867.Age started smoking in former smokers,30158,0.00611521117262251,0.00580734373728024,-0.00526718255244677,0.0174976048976918,0.292379407895497
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35687,-0.00277945134796352,0.0491643198935224,-0.0991415183392673,0.0935826156433403,0.954917486120813
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35679,0.0322473893610442,0.0534147501563917,-0.0724455209454836,0.136940299667572,0.546044051055638
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35718,0.132701739967546,0.05854192709657,0.0179595628582685,0.247443917076823,0.0234224717252182
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35672,0.1282484953462,0.0561215600276965,0.0182502376919145,0.238246753000485,0.0223201930673303
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28739.Difficulty with standing for long periods,35730,-0.138655456000606,0.049185660651179,-0.235059350876917,-0.0422515611242949,0.00482541870935194
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28740.Difficulty with taking care of household responsibilities,35759,-0.0825726906493233,0.0532483912756295,-0.186939537549557,0.0217941562509105,0.120999741883018
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28741.Difficulty learning a new task,35648,-0.10330986956472,0.0591328619332331,-0.219210278953857,0.0125905398244167,0.0806508019416052
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28742.Difficulty with joining in community activities,35368,-0.0733453490913588,0.0624623269848105,-0.195771509981587,0.0490808117988698,0.240327184084021
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28743.Difficulty with being emotionally affected by health problems,35680,-0.0738074644232845,0.0523894086417278,-0.176490705361071,0.0288757765145019,0.158914869421718
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35753,-0.0970162839595243,0.0765116588855168,-0.246979135375137,0.0529465674560886,0.204826411414544
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,30129,-0.0961335206316518,0.0605032339413945,-0.214719859156785,0.0224528178934815,0.112138920032546
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2897.Age stopped smoking,30168,-0.00355980802319086,0.00597476983068101,-0.0152703568913256,0.00815074084494391,0.551327939124794
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34599,0.0106882633559673,0.00824861972714332,-0.00547903130923361,0.0268555580211682,0.195086325834936
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34599,-0.0130554128037851,0.00879171796647481,-0.0302871800180757,0.00417635441050557,0.137583577344833
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34599,0.0215815341953335,0.0293837681781921,-0.0360106514339229,0.07917371982459,0.462678522206439
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34599,0.0306352338880108,0.0310017137626799,-0.0301281250868419,0.0913985928628635,0.323088689481355
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34599,-0.014491196853162,0.0323574071065277,-0.0779117147819562,0.0489293210756323,0.654272531424986
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34599,-0.00622760219728607,0.0269588848027276,-0.0590670164106322,0.0466118120160601,0.817316583281501
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34599,-0.00439258581421264,0.0124389383046243,-0.0287729048912764,0.0199877332628511,0.723996900529256
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34599,-0.0145977835926192,0.0219486828704945,-0.0576172020187883,0.0284216348335499,0.506009966205979
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29002.Recent lack of interest or pleasure in doing things,34526,0.00159914978110242,0.0591833456750054,-0.114400207741908,0.117598507304113,0.978444104798526
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29003.Recent feelings of depression,34510,-0.0206226019562572,0.056367109317795,-0.131102136219135,0.0898569323066211,0.714475502512524
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34530,-0.0391799586591956,0.0461624098954683,-0.129658282054313,0.0512983647359223,0.396045243285098
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29005.Recent feelings of tiredness or low energy,34538,-0.0205895698763377,0.0471435840278641,-0.112990994570951,0.0718118548182759,0.662308021905949
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29006.Recent poor appetite or overeating,34545,0.0604480799145672,0.060885907037141,-0.0588882978782292,0.179784457707364,0.320826820872384
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29007.Recent feelings of inadequacy,34498,0.0265915632781431,0.0612427636545569,-0.0934442534847885,0.146627380041075,0.664153069765778
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29008.Recent trouble concentrating on things,34545,-0.0355058276807754,0.0615022129751033,-0.156050165111978,0.0850385097504271,0.563743102600074
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34532,0.00643205638351482,0.109488146574298,-0.208164710902109,0.221028823669139,0.953155106482413
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29010.Recent thoughts of suicide or self-harm,34467,0.08242785737193,0.123241821969055,-0.159126113687417,0.323981828431277,0.503619193152911
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#0.Substances taken for depression_None of options listed,33208,0.0386123584455473,0.0161805006802531,0.00689857711225125,0.0703261397788433,0.0170376013744197
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),33208,0.0214627599032037,0.0323642210129363,-0.0419711132821513,0.0848966330885588,0.507243504331248
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),33208,0.0304935723921693,0.0152745472653684,0.000555459752047269,0.0604316850322913,0.0459251123491072
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),33208,0.101380357396433,0.0438913192578059,0.0153533716511333,0.187407343141732,0.0209221370139992
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),33208,0.0659347136385579,0.0278113823059026,0.0114244043189889,0.120445022958127,0.0177720415013939
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),33208,0.0172956458490444,0.0292336703853468,-0.0400023481062353,0.074593639804324,0.554110688726066
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),33208,0.0139517967111413,0.0334039948392166,-0.0515200331737233,0.0794236265960058,0.676199741001184
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),33208,0.0142344179614934,0.0388739799065428,-0.0619585826553305,0.0904274185783173,0.714248364110444
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),33208,0.0320787059005149,0.0298547403604987,-0.0264365852060625,0.0905939970070924,0.282631443342632
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,33208,0.0604984017500284,0.0163135214403553,0.028523899726932,0.0924729037731249,0.000209794123358321
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,33208,0.0525935553063357,0.0247281657501233,0.00412635043609396,0.101060760176577,0.0334588959270877
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,33208,-0.0284321141564421,0.0384250498920046,-0.103745211944771,0.046880983631887,0.459358091821981
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,33208,0.0780007699815848,0.0512148178175694,-0.0223802729408513,0.178381812904021,0.12779187540603
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,33208,0.0229217546913428,0.0328975055777713,-0.041557356241089,0.0874008656237746,0.485969811696023
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,33208,0.0939438711771642,0.056032444984145,-0.01587972099176,0.203767463346088,0.0936568647899769
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,33208,-0.00192434688807959,0.0541142784605399,-0.107988332670738,0.104139638894579,0.971633378362292
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,33208,0.00928037322410625,0.0283126699356049,-0.0462124598496794,0.0647732062978919,0.743084611387608
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,33208,-0.0177446848193749,0.0278394550475306,-0.0723100167125349,0.036820647073785,0.523885294009017
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,33208,0.0449927081013305,0.0384259819957296,-0.0303222166102995,0.12030763281296,0.241673708011372
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29058.Recent feelings or nervousness or anxiety,34379,-0.00253431728890039,0.0526633152608721,-0.10575441520021,0.100685780622409,0.961619175759039
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29059.Recent inability to stop or control worrying,34393,-0.0311484745658235,0.0540695087359325,-0.137124711688251,0.0748277625566042,0.56457275349401
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29060.Recent worrying too much about different things,34383,-0.0134385126145913,0.0507465477952566,-0.112901746293294,0.0860247210641116,0.791156482639096
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29061.Recent trouble relaxing,34389,-0.0202709555528242,0.0535225338475459,-0.125175121894014,0.0846332107883657,0.704891383468253
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29062.Recent restlessness,34402,-0.062350335159386,0.0775411736021885,-0.214331035419675,0.0896303651009034,0.421362330251183
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29063.Recent easy annoyance or irritability,34367,-0.0212398209512319,0.0557467628870099,-0.130503476209771,0.0880238343073075,0.703207363035101
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29064.Recent feelings of foreboding,34354,-3.89887555962034e-05,0.0606557297054759,-0.118924218978329,0.118846241467137,0.999487142623048
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,33208,0.0151287411083413,0.0159429747850619,-0.01611948947038,0.0463769716870627,0.342683232548378
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,33208,0.0113554839068033,0.0280752527405109,-0.0436720114645981,0.0663829792782047,0.685879987655826
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',33208,-0.00468978743589562,0.0349769438197431,-0.073244597322592,0.0638650224508008,0.893340614428391
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,33208,0.0795169250678782,0.0385676323534538,0.0039243656551088,0.155109484480648,0.0392607194486694
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#2.Symptoms of panic attack_Sweating,33208,0.0127482606308973,0.0261609100869419,-0.0385271231395087,0.0640236444013033,0.626056615869512
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,33208,0.0111787325092209,0.0258962222790451,-0.0395778631577076,0.0619353281761493,0.66598880847621
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,33208,0.0414040627949957,0.0265813370831281,-0.0106953578879354,0.0935034834779268,0.119355564810467
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,33208,0.00819643392228206,0.0238021559680429,-0.038455791775082,0.0548486596196461,0.730586253495596
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,33208,-0.0200282225804146,0.0323772054001172,-0.0834875451646443,0.043431100003815,0.53620243819861
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29076.Felt loved as a child,34358,0.00697190380681992,0.0497078434831753,-0.0904554694202037,0.104399277033844,0.888459300330508
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29077.Physically abused by family as a child,34372,0.000136375253204817,0.0694234410315844,-0.135933569168701,0.13620631967511,0.998432677862425
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29078.Felt hated by family member as a child,34351,0.0177571541213829,0.0645289497960639,-0.108719587478902,0.144233895721668,0.783182771492724
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29079.Sexually molested as a child,34240,-0.196799636336807,0.0819794348000452,-0.357479328544895,-0.036119944128718,0.0163868791490307
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29080.Someone to take to doctor when needed as a child,34326,0.0894759448776529,0.0694440850531727,-0.0466344618265656,0.225586351581871,0.197615987558589
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34353,-0.129653635659133,0.0848360570951978,-0.295932307565721,0.0366250362474543,0.126473851090183
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34270,-0.0389325395084991,0.0641767297647901,-0.164718929847488,0.0868538508304895,0.544100068954125
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34354,-0.0313245482536203,0.0717895700497124,-0.172032105551057,0.109383009043816,0.662600717619273
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34311,0.0806949215541246,0.0881388971922719,-0.0920573169427284,0.253447160050978,0.359929205158446
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34317,-0.0999733971739651,0.0882464633401467,-0.272936465320653,0.0729896709727225,0.25728864570141
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29086.Experienced a violent or sexual assault,34349,0.0137887461342528,0.0833903058860409,-0.149656253402387,0.177233745670893,0.868670382437227
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29087.Experienced a life-threatening injury or illness,34359,-7.47032055667174e-05,0.0598927106616518,-0.117464416102404,0.117315009691271,0.999004836915619
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29088.Experienced a marital separation or divorce,34367,0.0704915439214309,0.0529068962572405,-0.0332059727427605,0.174189060585622,0.182769367231594
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29089.Experienced the death of a spouse or partner,34375,0.0648372835486777,0.0669905284861424,-0.0664641522841614,0.196138719381517,0.333139147050862
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34360,0.0443606478177549,0.0671245148740382,-0.0872034013353599,0.17592469697087,0.508710387935632
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29091.Frequency of drinking alcohol,34375,0.0489975442550914,0.0448508398594083,-0.0389101018693488,0.136905190379532,0.274659493442793
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33102,0.0280271480806656,0.0546987324479433,-0.0791823675173032,0.135236663678634,0.608390349481614
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33120,0.0367742533824706,0.0561489270518756,-0.0732776436392056,0.146826150404147,0.512522909162981
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29104.Ever used cannabis,34368,-0.00420815007056941,0.0675237439027147,-0.13655468811989,0.128138387978751,0.950308428508361
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29108.Ever thought that life not worth living,34312,0.030005804276946,0.0538743780603345,-0.0755879767213097,0.135599585275202,0.577568280901846
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29109.Ever contemplated self-harm,34349,0.0859480906820443,0.0709671857811971,-0.0531475934491019,0.225043774813191,0.225887449537609
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29111.Ever self-harmed,34364,-0.0333232963234033,0.109713948613173,-0.248362635605221,0.181716042958415,0.761340818459726
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34358,-0.0172782902431719,0.0754119992206421,-0.16508580871563,0.130529228229287,0.818781482536144
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33945,0.0753755504509239,0.0347376984471946,0.00728966149442258,0.143461439407425,0.0300430295294959
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33945,0.0320936349239128,0.0266705182935393,-0.0201805809314242,0.0843678507792498,0.228875749120232
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33945,0.0174204512015438,0.0270753951101405,-0.0356473232143316,0.0704882256174192,0.519976723300132
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33945,0.0852192863321258,0.034799641952428,0.0170119881053668,0.153426584558885,0.0143490593804914
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34351,-0.0753760121745202,0.0493997213106491,-0.172199465943392,0.0214474415943521,0.127081962504625
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X29153.Pain or discomfort today,34364,-0.104450269015568,0.0476947381001177,-0.197931955691799,-0.0109685823393376,0.0285493016233392
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29154.Anxiety or depression today,34364,0.022485662673224,0.0572455123375979,-0.0897155415084678,0.134686866854916,0.694480487099678
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29166.Frequency of confiding in someone close,34113,-0.0498866384623683,0.046233746166472,-0.140504780948653,0.0407315040239168,0.280610565932743
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34326,-0.0143437952082668,0.00879184401318753,-0.0315758094741144,0.00288821905758073,0.102819107755598
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34326,0.00278760401999888,0.0086306558909576,-0.014128481526278,0.0197036895662758,0.746710666079959
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34326,-0.00871312643006197,0.0126001452176146,-0.0334094110565867,0.0159831581964627,0.48926135617689
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34326,0.00901567688835092,0.0110313491901393,-0.0126057675243222,0.030637121301024,0.413789404864493
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34326,-0.00566497788178379,0.0163994618442329,-0.0378079230964803,0.0264779673329127,0.729773362102502
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34326,0.0104343184135584,0.00862380731116406,-0.00646834391632313,0.02733698074344,0.226329592035682
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34329,-0.0115676727575733,0.00959218252543515,-0.0303683505074262,0.00723300499227955,0.227866451215966
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34329,0.0223098640742546,0.0134155087312463,-0.00398453303898816,0.0486042611874974,0.0963460574352177
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34329,0.0257945199279073,0.0279047246299105,-0.0288987403467172,0.0804877802025319,0.355312008125213
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34329,0.0182334479979878,0.0184795747247225,-0.0179865184624682,0.0544534144584438,0.32382314428345
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34329,-0.00547400808906599,0.0260672613740066,-0.056565840382119,0.045617824203987,0.833675501513395
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34329,-0.000297158475050094,0.0136723099269436,-0.0270948859318596,0.0265005689817595,0.982660319100864
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29171.Frequency of feeling 'in tune' with people,34217,0.0288846215518853,0.0577203269349404,-0.0842472192405979,0.142016462344369,0.616788023500021
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29172.Freuency of feeling that lacks companionship,34303,0.11044072380074,0.0516552613057332,0.00919641164150276,0.211685035959977,0.0325384913003427
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29173.Frequency of feeling left out,34242,0.101801937890504,0.053854383795442,-0.00375265434856226,0.20735653012957,0.0587448873090498
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29174.Frequency of feeling isolated from others,34274,0.0640908763914294,0.0559434220025166,-0.045558230733503,0.173739983516362,0.251973131514404
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29175.Tendency to bounce back quickly after hard times,34349,0.000169339970175263,0.0464178561313614,-0.0908096580472932,0.0911483379876437,0.997089265957722
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29176.Ability to make it through stressful events,34349,-0.00381326941728062,0.0454604390998135,-0.092915730052915,0.0852891912183538,0.933152702459287
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29177.Quick recovery from stressful events,34349,-0.0102380678091472,0.0460113510197854,-0.100420315807927,0.0799441801896322,0.823920093674101
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29178.Hard to snap back when something bad happens,34349,0.0153850886802694,0.0454604314944721,-0.0737173570488961,0.104487534409435,0.73504776216175
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29179.Comes through difficult times with little trouble,34349,0.00396550888316941,0.0459572903022243,-0.0861107801091902,0.094041797875529,0.931240153810567
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29180.Tendency to take a long time to get over setbacks,34349,0.0260828632003189,0.0459612865250559,-0.0640012583887905,0.116166984789428,0.570389869043887
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29181.General happiness,34289,0.0635107680693332,0.048125175777026,-0.0308145764536378,0.157836112592304,0.186966107289154
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29182.Belief that own life is meaningful,34193,-0.0186636167634008,0.0473633785896931,-0.111495838799199,0.0741686052723977,0.693551546106573
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29700,-0.0368394928856316,0.0615157648975534,-0.157410392084836,0.0837314063135731,0.549290344780846
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2946.Father's age,30787,-0.00116789275989216,0.00782900707120856,-0.0165127466194609,0.0141769610996766,0.881420231257271
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2966.Age high blood pressure diagnosed,30421,0.0106489774582249,0.00646599034020166,-0.00202436360857033,0.0233223185250202,0.0996268553135853
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30000.White blood cell (leukocyte) count,51529,-0.0534552047826575,0.00260478795871385,-0.0585605891817367,-0.0483498203835784,6.99402949525648e-93
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51529,0.0308059250561348,0.00307262340399011,0.0247835831843142,0.0368282669279554,1.28915693223895e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30020.Haemoglobin concentration,51529,0.0154269319649768,0.00334041909299167,0.00887971054271312,0.0219741533872405,3.88744950819237e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30030.Haematocrit percentage,51529,0.016922913307275,0.00324096236612225,0.0105706270696754,0.0232751995448746,1.78721785834957e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30040.Mean corpuscular volume,51529,-0.0222920197159799,0.00257498617365067,-0.0273389926163353,-0.0172450468156246,5.10142667347748e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51528,-0.0226007845919238,0.00257960408808774,-0.0276568086045758,-0.0175447605792718,2.03999375737067e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51528,-0.00432848255072121,0.0025281359428783,-0.00928362899876269,0.00062666389732026,0.0868852462661062
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51529,-0.0152766943996194,0.00243901902606832,-0.0200571716907134,-0.0104962171085255,3.82188590459548e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30080.Platelet count,51529,-0.0238113503629912,0.00258337536234238,-0.0288747660731823,-0.0187479346528001,3.26598132702768e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30090.Platelet crit,51529,-0.0207677632026045,0.00264953701750146,-0.0259608557569074,-0.0155746706483016,4.73537267410652e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51529,0.0122930472765023,0.00250353876664658,0.00738611129387502,0.0171999832591296,9.14810852363432e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30110.Platelet distribution width,51529,0.0180110619601188,0.00250062327477334,0.013109840341563,0.0229122835786745,6.06040590247622e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30120.Lymphocyte count,51490,-0.0226782533258329,0.00260554205748332,-0.0277851157585002,-0.0175713908931657,3.38725038249316e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30130.Monocyte count,51490,-0.0179698263745919,0.002645604297836,-0.0231552107983505,-0.0127844419508334,1.12619742112175e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30140.Neutrophill count,51490,-0.0536659693224304,0.00258445830705691,-0.058731507604262,-0.0486004310405989,4.96767386679831e-95
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30150.Eosinophill count,51490,0.0167912638910274,0.00256481485741093,0.0117642267705019,0.0218183010115528,5.98461201994943e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30160.Basophill count,51490,-0.223856249855849,0.0303554579001732,-0.283352947340188,-0.164359552371509,1.69702450794478e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30170.Nucleated red blood cell count,51490,0.473145016174273,0.135814510091671,0.206948576394597,0.739341455953949,0.000495206624927093
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30180.Lymphocyte percentage,51490,0.020147058418777,0.00257354617077127,0.0151029079240653,0.0251912089134886,5.11637847008335e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30190.Monocyte percentage,51490,0.0220121756281462,0.00260834762904677,0.0168998142752145,0.0271245369810779,3.35479862325783e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30200.Neutrophill percentage,51490,-0.02887358340334,0.00254736291829136,-0.0338664147231911,-0.023880752083489,1.03097495606155e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30210.Eosinophill percentage,51490,0.0362713753935393,0.00252746637459693,0.0313175412993293,0.0412252094877493,1.55981220083832e-46
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30220.Basophill percentage,51490,-0.00299391723620893,0.00242752440582045,-0.00775186507161701,0.00176403059919916,0.217466685002361
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30230.Nucleated red blood cell percentage,51490,0.47790519515234,0.135828482338117,0.211681369769632,0.744129020535049,0.000434794451472209
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30240.Reticulocyte percentage,51040,-0.0173457459621691,0.00266054931503803,-0.0225604226196436,-0.0121310693046946,7.17532023628658e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30250.Reticulocyte count,51040,-0.0118888249130885,0.00275100780356389,-0.0172808002080738,-0.00649684961810331,1.55446188618644e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30260.Mean reticulocyte volume,51040,-0.0177370268231481,0.00255016747404927,-0.0227353550722847,-0.0127386985740116,3.60107427488621e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30270.Mean sphered cell volume,51040,-0.0244452016293069,0.00257474748594551,-0.0294917067017601,-0.0193986965568537,2.39858698698649e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30280.Immature reticulocyte fraction,51040,-0.0196799857463478,0.00268877271987345,-0.0249499802772998,-0.0144099912153959,2.56295937757861e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51040,-0.022082326964858,0.00273290707367812,-0.0274388248292671,-0.0167258291004489,6.74045180445168e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30300.High light scatter reticulocyte count,51040,-0.0177628943888543,0.00280477696996745,-0.0232602572499905,-0.0122655315277181,2.44145917565916e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30500.Microalbumin in urine,32248,-0.0142694998683372,0.00514260363768159,-0.0243490029981931,-0.00418999673848127,0.00553737070653194
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51580,0.0067046347034116,0.00268663799629892,0.00143882423066571,0.0119704451761575,0.0125821585514077
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30520.Potassium in urine,51527,0.013135634373057,0.00249710980779404,0.00824129914978074,0.0180299695963334,1.44885589719396e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30530.Sodium in urine,51496,0.00625497127661586,0.00263322674875908,0.00109384684904805,0.0114160957041837,0.017536789936505
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30600.Albumin,48730,0.00029166119569377,0.00276317622177178,-0.00512416419897892,0.00570748659036646,0.915937987724666
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30610.Alkaline phosphatase,51135,0.046851486365314,0.00259786323882385,0.0417596744172192,0.0519432983134087,2.80209135480963e-72
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30620.Alanine aminotransferase,51144,-0.00687310124268778,0.00272329533349662,-0.0122107600963412,-0.00153544238903441,0.0116145607733095
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30630.Apolipoprotein A,48511,0.00228628606266234,0.00302582539184752,-0.00364433170535881,0.00821690383068348,0.449901924329164
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30640.Apolipoprotein B,51031,0.0126370729076948,0.00259687878775844,0.00754719048368826,0.0177269553317013,1.14384316251387e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30650.Aspartate aminotransferase,51064,0.00683957036176823,0.00263483779448949,0.00167528828456883,0.0120038524389676,0.00944167190191986
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30660.Direct bilirubin,45216,0.004850288282016,0.00299181272114988,-0.00101366465143777,0.0107142412154698,0.104992695633823
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30670.Urea,51130,0.0131376931693634,0.00271557693323797,0.00781516238021699,0.0184602239585098,1.31949138198428e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30680.Calcium,48738,-0.00733202457788116,0.00265048391580222,-0.0125269730528535,-0.00213707610290881,0.00567397948427197
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30690.Cholesterol,51143,0.0223096114680347,0.00267166773537585,0.017073142706698,0.0275460802293714,7.12623656762436e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30700.Creatinine,51136,0.00685984063917471,0.00296472335947815,0.00104898285459753,0.0126706984237519,0.0206850746258425
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30710.C-reactive protein,51076,-0.00447396721168964,0.00285858255728835,-0.0100767890239748,0.00112885460059554,0.117571377121015
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30720.Cystatin C,51138,0.0463363135262999,0.00290419021742019,0.0406441007001564,0.0520285263524435,4.83118347903722e-57
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30730.Gamma glutamyltransferase,51140,-0.0194603296357983,0.00267045616279529,-0.0246944237148771,-0.0142262355567196,3.25079475530959e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30740.Glucose,48710,-0.0138469368225132,0.00286040790904526,-0.0194533363242419,-0.00824053732078451,1.30050009390165e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50962,-0.0235411846618981,0.00289490860152406,-0.0292152055208852,-0.0178671638029109,4.40823516851233e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30760.HDL cholesterol,48723,0.00457853774172368,0.00318385842147254,-0.0016618247643625,0.0108189002478099,0.150433639745076
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30770.IGF-1,50993,-0.043639322207299,0.00260030657256476,-0.0487359230895259,-0.0385427213250721,6.93357115646929e-63
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30780.LDL direct,51088,0.0211301440132447,0.00260406643381329,0.0160261738029706,0.0262341142235187,5.09525311917219e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30790.Lipoprotein A,45809,0.00172517052919849,0.00285556847809602,-0.0038717436878697,0.00732208474626668,0.545755264708212
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30810.Phosphate,48689,0.0167421303554356,0.00285412217561026,0.0111480508912395,0.0223362098196317,4.52374690942891e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30830.SHBG,48461,0.000755191651767475,0.0030022694450003,-0.00512925646043312,0.00663963976396807,0.801398588546104
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30840.Total bilirubin,51045,0.0168401964293608,0.0026200963063022,0.0117048076690085,0.0219755851897131,1.32073185356231e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30850.Testosterone,46591,-0.0196565404263619,0.00455555638944816,-0.0285854309496803,-0.0107276499030435,1.60403804600689e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30860.Total protein,48728,-0.0188747969288665,0.00269365314863087,-0.024154357100183,-0.01359523675755,2.49599993743577e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30870.Triglycerides,51133,0.0158519804344163,0.00289791584178359,0.0101720653845204,0.0215318954843121,4.53738665307724e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30880.Urate,51105,0.00666519903873483,0.00318682662193558,0.000419018859741088,0.0129113792177286,0.0364940806405785
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30890.Vitamin D,49587,-0.00754642975017931,0.00285469286055089,-0.0131416277568591,-0.00195123174349957,0.00821005031708437
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3137.Number of measurements made,50011,-0.0377247353998696,0.0340074924886358,-0.104379420677596,0.0289299498778566,0.267308382402817
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3143.Ankle spacing width,40338,0.0220500419411066,0.00445305936623615,0.0133220455832838,0.0307780382989295,7.43377313633954e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40337,-0.00615201608704749,0.00361734336632567,-0.0132420090850458,0.000937976910950817,0.0890188967259473
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3146.Speed of sound through heel,40338,-0.0121804533803398,0.00348689254368364,-0.0190147627659597,-0.00534614399471981,0.000478546536852678
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40338,-0.0106610510716968,0.00353117503240672,-0.017582154135214,-0.0037399480081796,0.00253910078420434
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3148.Heel bone mineral density (BMD),40336,-0.010321678584485,0.00352180376487846,-0.0172244139636468,-0.00341894320532325,0.00338579329797982
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3526.Mother's age at death,41075,0.00748080371619062,0.0033763714628686,0.000863115648968161,0.0140984917834131,0.0267300689419329
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3581.Age at menopause (last menstrual period),40435,0.011409337760008,0.00330666193080661,0.00492828037562702,0.0178903951443889,0.00056118224260083
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30236,-0.00382939215104165,0.00567579915092623,-0.0149539584868571,0.00729517418477375,0.499901135960598
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4100.Ankle spacing width (left),33450,0.0178357828638897,0.00592360609127515,0.00622551492499041,0.029446050802789,0.00261139823743922
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33448,-0.00897002132098546,0.00485241837942008,-0.0184807613446488,0.00054071870267791,0.0645531299320174
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4103.Speed of sound through heel (left),33450,-0.00904404589245515,0.00473301427940359,-0.0183207538800862,0.000232662095175893,0.0560565405262123
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33450,-0.00944511002940658,0.00477161655610764,-0.0187974784793775,-9.27415794356075e-05,0.0477973567680155
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4105.Heel bone mineral density (BMD) (left),33448,-0.00892234973200553,0.00475610879548176,-0.0182443229711498,0.000399623507138708,0.0606908209398016
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33450,-0.00943638513276614,0.0047713513774104,-0.0187882338324905,-8.45364330417601e-05,0.0479910479929349
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4119.Ankle spacing width (right),33454,0.0186339084490196,0.00583697943115393,0.00719342876395788,0.0300743881340813,0.00141586433809216
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33454,-0.00851443027728557,0.00485400221600329,-0.018028274620652,0.000999414066080872,0.0794465159931475
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4122.Speed of sound through heel (right),33454,-0.0101316051028257,0.00474691187263996,-0.0194355523732,-0.000827657832451362,0.0328404974000824
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33454,-0.00994718116681527,0.00478037374344516,-0.0193167137039678,-0.000577648629662758,0.0374769820754473
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4124.Heel bone mineral density (BMD) (right),33451,-0.0100063552641378,0.00477080850562528,-0.0193571399351634,-0.000655570593112262,0.0359848679801897
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33454,-0.0099483153016153,0.00478038804045328,-0.0193178758609037,-0.000578754742326873,0.0374558286800478
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4194.Pulse rate,33721,-0.0246993831031196,0.00463440102810029,-0.0337828091181962,-0.015615957088043,1.00756568877817e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4195.Pulse wave reflection index,33721,0.00818010742190466,0.00465112170742312,-0.000936091124644661,0.017296305968454,0.0786549069155945
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4196.Pulse wave peak to peak time,33718,0.0049598144095965,0.00424202049900739,-0.00335454576845798,0.013274174587651,0.242348955440855
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4198.Position of the pulse wave peak,33721,-0.00392703619711711,0.00410952413429123,-0.0119817035003279,0.00412763110609371,0.339302365529186
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4199.Position of pulse wave notch,33721,-0.0175687860028305,0.00457194486023304,-0.0265297979288872,-0.00860777407677372,0.000122481610111317
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4200.Position of the shoulder on the pulse waveform,33721,-0.00405764367776138,0.0041054445828855,-0.012104315060217,0.00398902770469421,0.323003782571303
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4269.Number of triplets attempted (left),33618,0.088709956268847,0.147295984335178,-0.199990173028102,0.377410085565796,0.547018366967787
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4270.Volume level set by participant (left),33527,-0.0887699642655694,0.0465772747760213,-0.180061422826571,0.00252149429543248,0.0566993906620002
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4276.Number of triplets attempted (right),33619,-0.0124506186661662,0.141774424809903,-0.290328491293576,0.265427253961244,0.930021725903062
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4277.Volume level set by participant (right),33510,-0.0902604110602247,0.0466228690485663,-0.181641234395415,0.00112041227496527,0.0529026304900805
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4288.Time to answer,33792,-0.0118549145109476,0.00519016647352875,-0.022027640799064,-0.00168218822283124,0.0223873653819425
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4290.Duration screen displayed,33792,-0.0152803972109773,0.00461220643233753,-0.0243203218183588,-0.00624047260359569,0.000926405766070903
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X46.Hand grip strength (left),52354,0.00821128479752575,0.00378124429066608,0.00080004598782024,0.0156225236072313,0.0298955472765262
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X47.Hand grip strength (right),52359,0.00409075112347745,0.00376359974940368,-0.00328590438535376,0.0114674066323087,0.277079289728281
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X48.Waist circumference,52445,-0.0381015787341081,0.00503899168303279,-0.0479780024328524,-0.0282251550353638,4.11124790327861e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X4803.Tinnitus,33626,-0.0639039611126943,0.0561978322428382,-0.174051712308657,0.0462437900832684,0.25551573504377
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4825.Noisy workplace,33765,-0.0533103206537843,0.0800799461957208,-0.210267015197397,0.103646373889828,0.505610579115261
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4836.Loud music exposure frequency,33708,0.123044043041273,0.0935320866728546,-0.0602788468375219,0.306366932920068,0.188365233483546
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X49.Hip circumference,52442,0.0288635850013631,0.00427343691662331,0.0204876486447814,0.0372395213579447,1.4645009442086e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X50.Standing height,52440,0.0326620662618417,0.00349539160679903,0.0258110987125156,0.0395130338111678,9.91366083128349e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X5057.Number of older siblings,32677,-0.0402084914376499,0.0495726177243597,-0.137370822177395,0.0569538393020951,0.417330082697839
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X51.Seated height,52313,0.0289285685123357,0.00350631388320252,0.0220561933012587,0.0358009437234126,1.64725459595517e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5181.Ever had eye surgery,30737,0.119149110766446,0.112524241017646,-0.10139840162814,0.339696623161031,0.289697396451137
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5186.Duration visual-acuity screen displayed (right),30719,0.000863729482232845,0.00535311919926551,-0.00962838414832756,0.0113558431127933,0.871822401585793
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5188.Duration visual-acuity screen displayed (left),30721,0.00311955698132501,0.00530042066756838,-0.00726926752710902,0.013508381489759,0.556185096057864
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5190.Duration at which refractometer first shown (right),30645,0.00204683396176984,0.00534881931727485,-0.00843685190008887,0.0125305198236286,0.701977416767396
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5193.Duration at which refractometer first shown (left),30646,-0.00133368288042972,0.00537227200929699,-0.0118633360186518,0.00919597025779237,0.803946856954622
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5199.logMAR, initial (right)",30700,-0.0399057325977355,0.0586349452917556,-0.154830225369577,0.0750187601741055,0.496162923694369
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5200.Final number of letters displayed (right),30700,0.265518123114011,0.425044530227084,-0.567569156131074,1.09860540235909,0.53220190298886
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5201.logMAR, final (right)",30648,-0.00248038246712984,0.00557281278402753,-0.0134030955238238,0.00844233058956411,0.656272957304384
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5202.Number of rounds to result (right),30700,0.0238919673824328,0.0553527390415124,-0.0845994011389315,0.132383335903797,0.666024421340336
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5206.logMAR, initial (left)",30698,-0.0534057429377195,0.058840439284165,-0.168733003934683,0.0619215180592439,0.364105212015318
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5207.Final number of letters displayed (left),30698,0.395883253040095,0.346625746377879,-0.283503209860549,1.07526971594074,0.253453865767807
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5208.logMAR, final (left)",30635,-0.00644883670336107,0.00550216062570372,-0.0172330715297404,0.00433539812301822,0.241220000117289
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5209.Number of rounds to result (left),30696,0.0137001838671841,0.0555305316542389,-0.0951396581751242,0.122540025909492,0.805137357377679
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30398,0.00290974616180242,0.00547848420217262,-0.00782808287445591,0.0136475751980607,0.595353739635436
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30398,-0.000746643659455006,0.00551780299172376,-0.0115615375232336,0.0100682502043236,0.892367098481913
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5256.Corneal hysteresis (right),30398,-0.00624029806742147,0.00548269687979418,-0.0169863839518181,0.00450578781697512,0.255091023379643
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5257.Corneal resistance factor (right),30398,-0.00527180569065943,0.00549102579324365,-0.016034216245417,0.00549060486409813,0.337055673169591
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30398,-0.0111088538289836,0.00543960993907934,-0.0217704893095791,-0.000447218348388059,0.0411742193748485
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30398,-0.011075581567365,0.00541120179333783,-0.0216815370823072,-0.000469626052422862,0.040722799744979
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5264.Corneal hysteresis (left),30398,0.00283323800124864,0.00555668215889017,-0.00805785903017609,0.0137243350326734,0.610154849361066
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5265.Corneal resistance factor (left),30398,-0.00291809307507854,0.00549258688469607,-0.0136835633690828,0.00784737721892576,0.595245677899001
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29979,-0.202040867881498,0.258592573438866,-0.708882311821676,0.304800576058679,0.434653878331086
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52353,0.00358940689458502,0.014735190291065,-0.0252915660759024,0.0324703798650725,0.807546911453924
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52353,0.00111336480017472,0.0151341222723935,-0.0285495148537165,0.0307762444540659,0.941355834652187
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52353,0.00770675435265957,0.0385667967514746,-0.0678841672802307,0.0832976759855499,0.841615980629502
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52353,-0.0343164780245054,0.00640905367764977,-0.0468782232326989,-0.0217547328163118,8.65305493820388e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52353,0.0290672878329002,0.00585919497962353,0.017583265672838,0.0405513099929623,7.05543081970056e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37385,0.00322159169614476,0.00735369404227248,-0.0111916486267093,0.0176348320189988,0.661327189476203
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37385,-0.0231038185574451,0.0183248228627554,-0.0590204713684458,0.0128128342535556,0.20740598078166
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37385,0.00162353932319191,0.0143363446353746,-0.0264756961621424,0.0297227748085262,0.909836973393839
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37385,0.00262248458332953,0.00883937724838411,-0.0147026948235033,0.0199476639901624,0.766714024821189
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52438,0.00110957078041337,0.0121025716324784,-0.0226114696192443,0.024830611180071,0.926952483913138
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52438,0.00110957078041337,0.0121025716324784,-0.0226114696192443,0.024830611180071,0.926952483913138
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52438,0.0093846995264266,0.00965922587164328,-0.00954738318199423,0.0283167822348474,0.331268507534616
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52438,0.0435330245647096,0.0151094160832056,0.0139185690416266,0.0731474800877926,0.00396483877654071
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52438,-0.019717659684166,0.0374170551837914,-0.0930550878443972,0.0536197684760651,0.598218707805193
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52438,0.0219074994514157,0.0255655388561522,-0.0282009567066427,0.0720159556094741,0.391499076029487
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52438,-0.0266895946125227,0.0419334636640284,-0.108879183394018,0.0554999941689729,0.524472179707979
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52353,-0.0126545700907796,0.0077569721761022,-0.0278582355559399,0.00254909537438068,0.102821426111092
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52353,-0.0215164082593441,0.0129401042616714,-0.04687901261222,0.00384619609353183,0.0963698539409608
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52353,0.0160744858593416,0.00687234797257044,0.00260468383310359,0.0295442878855797,0.0193419709949343
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52353,-0.0327064295084383,0.0127560193606649,-0.0577082274553416,-0.00770463156153507,0.0103525521931782
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52353,-0.00794411152239274,0.0124224922159823,-0.0322921962657181,0.0164039732209326,0.522506746361766
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52353,-0.0175687676301382,0.00696578674236519,-0.031221709645174,-0.00391582561510245,0.0116694718638787
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31934,0.0167754775872612,0.0270128600975803,-0.0361697282039963,0.0697206833785186,0.534606570170543
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31934,-0.03215440041828,0.0176635457249886,-0.0667749500392577,0.0024661492026976,0.0687407850629801
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31934,-0.0067691443725155,0.0226814429105629,-0.0512247724772188,0.0376864837321878,0.765372470068385
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31934,-0.0132088107055323,0.020128784371791,-0.0526612280742426,0.026243606663178,0.511705963608946
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52346,0.00438580218459809,0.0189564617170958,-0.0327688627809097,0.0415404671501059,0.817035392029923
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52346,-0.0131352597967261,0.0322604516297013,-0.0763657449909407,0.0500952253974885,0.683891455259506
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52346,0.0418197221489647,0.0517916497435383,-0.0596919113483703,0.1433313556463,0.419407988625194
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52346,-0.0839359372629067,0.0505781918613579,-0.183069193311168,0.0151973187853547,0.0970206381683599
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52346,0.0135420244791456,0.0158811601101484,-0.0175850493367453,0.0446690982950365,0.39382745001896
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52346,-0.0342383975033029,0.0226168472123602,-0.0785674180395289,0.0100906230329231,0.130076526308617
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52346,-0.0020158909461935,0.0112065362908681,-0.023980702076295,0.019948920183908,0.857243936285259
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34056,0.036896549671091,0.0172403472727474,0.00310546901650609,0.0706876303256759,0.0323695430802642
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34056,-0.0707660475051858,0.0199867738324592,-0.109940124216806,-0.0315919707935658,0.000401042057571978
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34056,0.0142742779300538,0.0259638061673674,-0.0366147821579863,0.0651633380180938,0.582485794559514
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34056,-0.0260632440992979,0.00899030401364598,-0.0436842399660441,-0.0084422482325518,0.00375155791648383
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37657,-0.0320915351040049,0.00906422217471194,-0.0498574105664403,-0.0143256596415695,0.00040080174197969
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37657,0.0167900353640533,0.00791138047904669,0.00128372962512184,0.0322963411029849,0.0338341641071955
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37657,0.0159262814803559,0.00741834080852996,0.00138633349563721,0.0304662294650747,0.03182105698664
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37657,-0.0350304478567361,0.0177399721152356,-0.0698007932025979,-0.000260102510874285,0.0483273240514337
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37657,-0.0389401092113173,0.0106800760966927,-0.059873058360835,-0.0180071600617997,0.000267323683525735
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37657,-0.00290427192204608,0.0123817243612336,-0.027172451670064,0.0213639078259719,0.814552976674616
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52353,-0.0210560521811647,0.0168940256521543,-0.0541683424593871,0.0120562380970577,0.21264241132615
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52353,-0.00465565999154899,0.010871700987677,-0.0259641939273959,0.0166528739442979,0.668482196130739
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52353,-0.028185385755811,0.0422432316270493,-0.110982119744828,0.0546113482332057,0.504639301536971
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52353,-0.0444942150841007,0.0107332509550549,-0.0655313869560082,-0.0234570432121932,3.40139603804887e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52353,-0.0216057066340145,0.0128537791622514,-0.0467991137920273,0.00358770052399835,0.0927967184940023
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52353,-0.0627008817389016,0.0144428359346103,-0.0910088401707378,-0.0343929233070654,1.42131724006739e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52353,0.0128680417023463,0.00511995698256204,0.00283292601652466,0.0229031573881679,0.0119659884111041
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28871,-0.0202003113055008,0.0176889656350191,-0.0548706839501382,0.0144700613391366,0.253527333797595
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28871,-0.0421450724829159,0.0233768766485946,-0.0879637507141613,0.0036736057483296,0.0714793877465328
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28871,0.035938870387394,0.0155104344178171,0.00553841892847241,0.0663393218463156,0.0205450148788771
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28871,-0.00762693746294929,0.0140346680193568,-0.0351348867808887,0.0198810118549901,0.586857363596249
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52479,0.00214486397211893,0.00584904076787254,-0.00931925593291126,0.0136089838771491,0.713842931830404
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52479,-0.0255500382996898,0.0156541166753362,-0.0562321069833488,0.00513203038396922,0.102656814187913
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52479,-0.010763273574042,0.00570869179236995,-0.0219523094870871,0.000425762339003049,0.0593836814545222
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52479,-0.00618375945645031,0.00569545280975568,-0.0173468469635714,0.00497932805067084,0.277605045524517
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52479,-0.0174725731724046,0.00822583013054671,-0.0335952002282762,-0.00134994611653309,0.0336696251613734
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52479,-0.00257862260638063,0.00728517940565413,-0.0168575742414627,0.0117003290287015,0.723375586048861
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52479,-2.63085859184171e-05,0.0061042553642859,-0.0119906490999188,0.0119380319280819,0.996561257509552
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52479,-0.0421306795468204,0.0166525363314796,-0.0747696507565203,-0.00949170833712044,0.0114121463246369
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43728,0.0137076572192121,0.00607273586301994,0.00180509492769305,0.0256102195107312,0.0240038675094407
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43728,-0.00678139784039123,0.0067298281436797,-0.0199718610020034,0.00640906532122099,0.313628991579588
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43728,0.00267423230481605,0.00675944392712257,-0.0105742777923442,0.0159227424019763,0.692383089771477
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43728,0.0037142178157192,0.00863316310579726,-0.0132067818716434,0.0206352175030818,0.667035505502085
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43728,0.00439677291220283,0.00611622094588566,-0.00759102014173307,0.0163845659661387,0.472229216355901
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52229,0.00148821924042647,0.00617354148266759,-0.010611922065602,0.0135883605464549,0.80950721326422
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52229,0.00924655923007987,0.00495866636663979,-0.000472426848534128,0.0189655453086939,0.0622302132235501
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52229,-0.00657709523202745,0.00542560542174617,-0.0172112818586499,0.00405709139459504,0.225433704161605
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52229,0.0371584718675618,0.0118867950513207,0.0138603535669733,0.0604565901681502,0.00177366440196464
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52241,0.0205815018677495,0.00559843491109522,0.00960856944200289,0.0315544342934962,0.000237090642475042
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52241,0.0165603499426364,0.010052951446871,-0.00314343489323085,0.0362641347785036,0.0995051901546798
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52353,-0.00284397827705326,0.00535349040120523,-0.0133368194634155,0.00764886290930899,0.595257995948175
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52353,0.0107808298025443,0.00607756220193097,-0.00113119211324036,0.022692851718329,0.0760948923219911
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52353,-0.0123711989711715,0.00794221352469739,-0.0279379374795784,0.00319553953723537,0.119327280325807
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52353,-0.0103005046269538,0.0114538422968572,-0.0327500355287939,0.0121490262748863,0.368497661467324
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52353,-0.00356998506852811,0.0118540005937362,-0.0268038262322511,0.0196638560951949,0.763292531155299
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52353,-0.0238200145492819,0.0153353453510529,-0.0538772914373456,0.00623726233878188,0.120368698949991
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40338,-0.0106591531338068,0.00353116887704765,-0.0175802441328202,-0.0037380621347934,0.00254356243764381
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X864.Number of days or week walked 10+ minutes,51832,0.0387350514896363,0.0272190756203411,-0.0146143367262322,0.0920844397055049,0.154722984071495
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X874.Duration of walks,47707,0.00968499052282132,0.00275428895446697,0.00428658417206606,0.0150833968735766,0.000438388962263174
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50740,0.0621244411759398,0.0263928229421744,0.0103945082092779,0.113854374142602,0.0185880050663527
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X894.Duration of moderate activity,44491,-0.0112943473883695,0.0324384092209899,-0.0748736294615097,0.0522849346847707,0.727710005653633
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X90087.No-wear time bias adjusted average acceleration,30528,0.0131689836382255,0.00570285552844331,0.00199138680247658,0.0243465804739743,0.0209663552572082
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50730,0.0639440212630123,0.0273641052734124,0.0103103749271241,0.117577667598901,0.0194578582492717
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X914.Duration of vigorous activity,38284,0.000763114284563523,0.00366764466899194,-0.00642546926666067,0.00795169783578772,0.835180044394996
